UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~July 31,~~October 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number

0-13200

AstroNova, Inc.

(Exact name of registrant as specified in its charter)


Rhode Island		05-0318215
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

600 East Greenwich Avenue, West Warwick, Rhode Island		02893
(Address of principal executive offices)		(Zip Code)

(401)

828-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $.05 Par Value	ALOT	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act) Yes ☐ No ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of ~~September~~

,December 3, 2021 was ~~7,254,136.~~

7,256,418

Table of Contents

ASTRONOVA, INC.

INDEX


		Page No.
Part I.	Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets – ~~July 31,~~October 30, 2021 and January 31, ~~2020~~2021		3
	Unaudited Condensed Consolidated Statements of Income — Three and ~~Six~~Nine Months Ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020		4
	Unaudited Condensed Consolidated Statements of Comprehensive Income — Three and ~~Six~~Nine Months Ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020		5
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity — Three and ~~Six~~Nine Months Ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020		66-7
	Unaudited Condensed Consolidated Statements of Cash Flows — ~~Six~~Nine Months Ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020		78
	Notes to the Condensed Consolidated Financial Statements (unaudited)		~~8-21~~9-25
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		~~21-32~~ 25-37
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		3237
Item 4.	Controls and Procedures		3237
Part II.	Other Information
Item 1.	Legal Proceedings		3237
Item 1A.	Risk Factors		~~32-33~~ 37-38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		3439
Item 6.	Exhibits		3540
Signatures				3641

Part I. FINANCIAL INFORMATION

Item 1.

Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In

~~housands,~~ Thousands, Except Share Data)

July 31,
2021

January 31,
2021


(Unaudited)

ASSETS

CURRENT ASSETS

Cash and Cash Equivalents
   $ 11,389 $ 11,439
Accounts Receivable, net
   15,603 17,415
Inventories, net
   29,090 30,060
Prepaid Expenses and Other Current Assets
   5,317 1,807


Total Current Assets
   61,399 60,721
Property, Plant and Equipment, net
   12,307 12,011
Intangible Assets, net
   20,074 21,502
Goodwill
   12,623 12,806
Deferred Tax Assets
   5,942 5,941
Right of Use Assets
   1,209 1,389
Other Assets
   1,680 1,103


TOTAL ASSETS
   $ 115,234 $ 115,473


LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES

Accounts Payable
   $ 6,131 $ 5,734
Accrued Compensation
   3,917 2,852
Other Liabilities and Accrued Expenses
   3,666 3,939
Current Liability – Royalty Obligation
   2,000 2,000
Current Portion of Long-Term Debt
   875 5,326
Current Liability – Excess Royalty Payment Due
   24 177
Deferred Revenue
   324 285
Income Taxes Payable
   —   655


Total Current Liabilities
   16,937 20,968
Long-Term Debt, net of current portion
   8,641 7,109
Royalty Obligation, net of current portion
   5,261 6,161
Long-Term Debt – PPP Loan
   —   4,422
Lease Liabilities, net of current portion
   907 1,065
Other Long-Term Liabilities
   557 681
Deferred Tax Liabilities
   354 384


TOTAL LIABILITIES
   32,657 40,790
SHAREHOLDERS’ EQUITY

Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,554,475 shares and 10,425,094 shares at July 31, 2021 and January 31, 2021, respectively
   526 521
Additional
Paid-in
Capital
   59,078 58,049
Retained Earnings
   57,697 50,085
Treasury Stock, at Cost, 3,321,955 and 3,297,058 shares at July 31, 2021 and January 31, 2021, respectively
   (33,942 ) (33,588 )
Accumulated Other Comprehensive Loss, net of tax
   (782 ) (384 )


TOTAL SHAREHOLDERS’ EQUITY
   82,577 74,683


TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   $ 115,234 $ 115,473


	October 30, 2021			January 31, 2021
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	8,727		$	11,439
Accounts Receivable, net		16,351			17,415
Inventories, net		31,661			30,060
Prepaid Expenses and Other Current Assets		6,451			1,807

Total Current Assets		63,190			60,721
Property, Plant and Equipment, net		11,674			12,011
Intangible Assets, net		19,637			21,502
Goodwill		12,415			12,806
Deferred Tax Assets		5,942			5,941
Right of Use Assets		1,106			1,389
Other Assets		1,658			1,103

TOTAL ASSETS	$	115,622		$	115,473

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	6,866		$	5,734
Accrued Compensation		4,370			2,852
Other Liabilities and Accrued Expenses		3,835			3,939
Current Liability – Royalty Obligation		2,000			2,000
Current Portion of Long-Term Debt		938			5,326
Current Liability – Excess Royalty Payment Due		220			177
Deferred Revenue		284			285
Income Taxes Payable		—			655

Total Current Liabilities		18,513			20,968
Long-Term Debt, net of current portion		8,397			7,109
Royalty Obligation, net of current portion		4,811			6,161
Long-Term Debt – PPP Loan		—			4,422
Lease Liabilities, net of current portion		826			1,065
Other Long-Term Liabilities		557			681
Deferred Tax Liabilities		336			384

TOTAL LIABILITIES		33,440			40,790
SHAREHOLDERS’ EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,556,891 shares and 10,425,094 shares at October 30, 2021 and January 31, 2021, respectively		528			521
Additional Paid-in Capital		59,502			58,049
Retained Earnings		57,272			50,085
Treasury Stock, at Cost, 3,322,115 and 3,297,058 shares at October 30, 2021 and January 31, 2021, respectively		(33,944	)		(33,588	)
Accumulated Other Comprehensive Loss, net of tax		(1,176	)		(384	)

TOTAL SHAREHOLDERS’ EQUITY		82,182			74,683

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	115,622		$	115,473

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In

~~housands,~~ Thousands, Except Per Share Data)

(Unaudited)


	Three Months Ended						Six Months Ended						Three Months Ended						Nine Months Ended
	July 31, 2021			August 1, 2020			July 31, 2021			August 1, 2020			October 30, 2021			October 31, 2020			October 30, 2021			October 31, 2020
Revenue	$	29,845		$	27,658		$	58,923		$	58,578		$	28,857		$	28,017		$	87,780		$	86,595
Cost of Revenue		17,129			17,871			35,320			37,935			18,472			18,282			53,792			56,218

Gross Profit		12,716			9,787			23,603			20,643			10,385			9,735			33,988			30,377
Operating Expenses:
Selling and Marketing		5,061			5,555			11,154			11,481			5,777			5,553			16,931			17,033
Research and Development		1,539			1,493			3,255			3,433			1,948			1,412			5,203			4,845
General and Administrative		2,664			2,535			5,008			4,861			2,364			2,353			7,372			7,214

Operating Expenses		9,264			9,583			19,417			19,775			10,089			9,318			29,506			29,092

Operating Income		3,452			204			4,186			868			296			417			4,482			1,285
Other Income (Expense), net:
Extinguishment of Debt – PPP Loan		4,466			—			4,466			—			0			—			4,466			—
Loss on Disposal of Assets														(696	)		0			(696	)		0
Interest Expense		(171	)		(259	)		(392	)		(490	)		(135	)		(286	)		(526	)		(776	)
Gain (Loss) on Foreign Currency Transactions		50			553			(114	)		399			(117	)		(85	)		(231	)		314
Other, net		(79	)		34			(63	)		68			53			(66	)		(11	)		3

		4,266			328			3,897			(23	)		(895	)		(437	)		3,002			(459	)

Income Before Income Taxes		7,718			532			8,083			845
Income Tax Provision		699			529			471			411
Income (Loss) Before Income Taxes														(599	)		(20	)		7,484			826
Income Tax Provision (Benefit)														(174	)		(32	)		297			379

Net Income	$	7,019		$	3		$	7,612		$	434
Net Income (Loss)													$	(425	)	$	12		$	7,187		$	447

Net Income per Common Share—Basic :	$	0.97		$	0.00		$	1.06		$	0.06
Net Income (Loss) per Common Share—Basic:													$	(0.06	)	$	0.00		$	1.00		$	0.06

Net Income per Common Share—Diluted :	$	0.96		$	0.00		$	1.04		$	0.06
Net Income (Loss) per Common Share—Diluted:													$	(0.06	)	$	0.00		$	0.98		$	0.06

Weighted Average Number of Common Shares Outstanding:
Basic		7,209			7,105			7,177			7,089			7,234			7,120			7,196			7,100
Diluted		7,329			7,123			7,297			7,114			7,234			7,185			7,325			7,137

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)


	Three Months Ended						Six Months Ended						Three Months Ended						Nine Months Ended
	July 31, 2021			August 1, 2020			July 31, 2021			August 1, 2020			October 30, 2021			October 31, 2020			October 30, 2021			October 31, 2020
Net Income	$	7,019		$	3		$	7,612		$	434
Net Income (Loss)													$	(425	)	$	12		$	7,187		$	447
Other Comprehensive Income (Loss), Net of Taxes:
Foreign Currency Translation Adjustments		(348	)		351			(429	)		210			(410	)		(157	)		(839	)		53
Change in Value of Derivatives Designated as Cash Flow Hedge		—			(229	)		—			(270	)		—			15			—			(255	)
Loss from Cash Flow Hedges Reclassified to Income Statement		15			232			31			193			16			0			47			193
Cross-Currency Interest Rate Swap Termination		—			45			—			45			—			0			—			45

Other Comprehensive Income (Loss)		(333	)		399			(398	)		178			(394	)		(142	)		(792	)		36

Comprehensive Income	$	6,686		$	402		$	7,214		$	612
Comprehensive Income (Loss)													$	(819	)	$	(130	)	$	6,395		$	483

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

($ In Thousands, Except per Share Data)

(Unaudited)

Common Stock

Additional
Paid-in

Retained

Treasury

Accumulated
Other
Comprehensive

Total
Shareholders’


Shares

Amount

Capital

Earnings

Stock

Income (Loss)

Equity

Balance January 31, 2021
   10,425,094    $ 521    $ 58,049 $ 50,085    $ (33,588 ) $ (384 ) $ 74,683
Share-Based Compensation
   —      —      478 —      —   —   478
Employee Option Exercises
   5,746    —      52 —      —   —   52
Restricted Stock Awards Vested, net
   48,299    3    (3 ) —      (208 ) —   (208 )
Net Income
   —      —      —   593    —   —   593
Other Comprehensive Loss
   —      —      —   —      —   (65 ) (65 )








Balance May 1, 2021
   10,479,139    $ 524    $ 58,576 $ 50,678    $ (33,796 ) $ (449 ) $ 75,533
Share-Based Compensation
   —      —      469 —      —   —   469
Employee Option Exercises
   3,211    —      35 —      —   —   35
Restricted Stock Awards Vested, net
   72,125    2    (2 ) —      (146 ) —   (146 )
Net Income
   —      —      —   7,019    —   —   7,019
Other Comprehensive Income
   —      —      —   —      —   (333 ) (333 )








Balance July 31, 2021
   10,554,475    $ 526    $ 59,078 $ 57,697    $ (33,942 ) $ (782 ) $ 82,577


	Common Stock				Additional Paid-in			Retained			Treasury			Accumulated Other Comprehensive			Total Shareholders’
	Shares		Amount		Capital			Earnings			Stock			Income (Loss)			Equity

Balance January 31, 2021		10,425,094	$	521	$	58,049		$	50,085		$	(33,588	)	$	(384	)	$	74,683
Share-Based Compensation		—		—		478			—			—			—			478
Employee Option Exercises		5,746		—		52			—			—			—			52
Restricted Stock Awards Vested, net		48,299		3		(3	)		—			(208	)		—			(208	)
Net Income		—		—		—			593			—			—			593
Other Comprehensive Loss		—		—		—			—			—			(65	)		(65	)

Balance May 1, 2021		10,479,139	$	524	$	58,576		$	50,678		$	(33,796	)	$	(449	)	$	75,533
Share-Based Compensation		—		—		469			—			—			—			469
Employee Option Exercises		3,211		—		35			—			—			—			35
Restricted Stock Awards Vested, net		72,125		4		(4	)		—			(146	)		—			(146	)
Net Income		—		—		—			7,019			—			—			7,019
Other Comprehensive Loss		—		—		—			—			—			(333	)		(333	)

Balance July 31, 2021		10,554,475	$	528	$	59,076		$	57,697		$	(33,942	)	$	(782	)	$	82,577
Share-Based Compensation		—		—		399			—			—			—			399
Employee Option Exercises		1,983		—		27			—			—			—			27
Restricted Stock Awards Vested, net		433		—		—			—			(2	)		—			(2	)
Net Loss		—		—		—			(425	)		—			—			(425	)
Other Comprehensive Loss		—		—		—			—			—			(394	)		(394	)

Balance October 30, 2021		10,556,891	$	528	$	59,502		$	57,272		$	(33,944	)	$	(1,176	)	$	82,182

Common Stock

Additional
Paid-in

Capital

Retained
Earnings

Treasury
Stock

Accumulated
Other
Comprehensive
Income (Loss)

Total
Shareholders’
Equity


Shares

Amount

Balance January 31, 2020
   10,343,610    $ 517    $ 56,130 $ 49,298 $ (33,477 ) $ (1,093 ) $ 71,375
Share-Based Compensation
   —      —      495 —   —   —   495
Employee Option Exercises
   4,456    —      32 —   —   —   32
Restricted Stock Awards Vested, net
   23,638    1    (1 ) —   (54 ) —   (54 )
Common Stock – Cash Dividend - $0.07 per share
   —      —      —   (497 ) —   —   (497 )
Net Income
   —      —      —   432 —   —   432
Other Comprehensive Loss
   —      —      —   —   —   (221 ) (221 )






Balance May 2, 2020
   10,371,704    $ 518    $ 56,656 $ 49,233 $ (33,531 ) $ (1,314 ) $ 71,562
Share-Based Compensation
   —      —      601 —   —   —   601
Employee Option Exercises
   4,874    —      29 —   —   —   29
Restricted Stock Awards Vested, net
   35,676    2    (2 ) —   (37 ) —   (37 )
Net Income
   —      —      —   3 —   —   3
Other Comprehensive Income
   —      —      —   —   —   399 399






Balance August 1, 2020
   10,412,254    $ 520    $ 57,284 $ 49,236 $ (33,568 ) $ (915 ) $ 72,557

Table of Contents


	Common Stock				Additional Paid-in			Retained			Treasury			Accumulated Other Comprehensive			Total Shareholders’
	Shares		Amount		Capital			Earnings			Stock			Income (Loss)			Equity

Balance January 31, 2020		10,343,610	$	517	$	56,130		$	49,298		$	(33,477	)	$	(1,093	)	$	71,375
Share-Based Compensation		—		—		495			—			—			—			495
Employee Option Exercises		4,456		—		32			—			—			—			32
Restricted Stock Awards Vested, net		23,638		1		(1	)		—			(54	)		—			(54	)
Common Stock – Cash Dividend - $0.07 per share		—		—		—			(497	)		—			—			(497	)
Net Income		—		—		—			432			—			—			432
Other Comprehensive Loss		—		—		—			—			—			(221	)		(221	)

Balance May 2, 2020		10,371,704	$	518	$	56,656		$	49,233		$	(33,531	)	$	(1,314	)	$	71,562
Share-Based Compensation		—		—		601			—			—			—			601
Employee Option Exercises		4,874		—		29			—			—			—			29
Restricted Stock Awards Vested, net		35,676		2		(2	)		—			(37	)		—			(37	)
Net Income		—		—		—			3			—			—			3
Other Comprehensive Income		—		—		—			—			—			399			399

Balance August 1, 2020		10,412,254	$	520	$	57,284		$	49,236		$	(33,568	)	$	(915	)	$	72,557

Share-Based Compensation		—		—		591			—			—			—			591
Employee Option Exercises		4,037		1		19			—			—			—			20
Restricted Stock Awards Vested, net		433		—		—			—			—			—			—
Net Income		—		—		—			12			—			—			12
Other Comprehensive (Loss)		—		—		—			—			—			(142	)		(142	)

Balance October 31, 2020		10,416,724	$	521	$	57,894		$	49,248		$	(33,568	)	$	(1,057	)	$	73,038

Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)


	Six Months Ended						Nine Months Ended
	July 31, 2021			August 1, 2020			October 30, 2021			October 31, 2020
Cash Flows from Operating Activities:
Net Income	$	7,612		$	434		$	7,187		$	447
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization		2,274			3,133			3,070			4,571
Amortization of Debt Issuance Costs		31			24			38			48
Share-Based Compensation		947			1,096			1,345			1,687
Loss on Disposal of Assets								696			—
Gain on Extinguishment of Debt		(4,466	)		—			(4,466	)		—
Changes in Assets and Liabilities:
Accounts Receivable		1,777			5,069			969			4,248
Other Receivable – Employee Retention Credit Receivable		(3,135	)		—			(3,135	)		—
Inventories		895			1,767			(1,804	)		3,252
Income Taxes		(1,241	)		143			(1,965	)		115
Accounts Payable and Accrued Expenses		1,282			(1,244	)		2,914			(1,488	)
Other		(483	)		(1,258	)		(1,001	)		(1,213	)

Net Cash Provided by Operating Activities		5,493			9,164			3,848			11,667
Cash Flows from Investing Activities:
Additions to Property, Plant and Equipment		(1,162	)		(1,201	)		(1,507	)		(2,102	)

Net Cash Used for Investing Activities		(1,162	)		(1,201	)		(1,507	)		(2,102	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans		43			6			47			6
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan		44			55			67			75
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock		(354	)		(91	)		(356	)		(91	)
Borrowings under Revolving Credit Facility		—			5,000			—			5,000
Repayment under Revolving Credit Facility		—			(9,500	)		—			(11,500	)
Payment of Minimum Guarantee Royalty Obligation		(1,000	)		(1,000	)		(1,500	)		(1,500	)
Proceeds from Long-Term Debt – PPP Loan		—			4,422			—			4,422
Proceeds from Long-Term Debt Borrowings		10,000			15,232			10,000			15,232
Payoff of Long-Term Debt		(12,576	)		(11,732	)		(12,576	)		(11,732	)
Principal Payments of Long-Term Debt		(375	)		(2,104	)		(563	)		(2,906	)
Payment of Debt Issuance Costs		—			(89	)		—			(89	)
Dividends Paid		—			(497	)		—			(497	)

Net Cash Used for Financing Activities		(4,218	)		(298	)		(4,881	)		(3,580	)

Effect of Exchange Rate Changes on Cash and Cash Equivalents		(163	)		(679	)		(172	)		(631	)

Net Increase (Decrease) in Cash and Cash Equivalents		(50	)		6,986			(2,712	)		5,354
Cash and Cash Equivalents, Beginning of Period		11,439			4,249			11,439			4,249

Cash and Cash Equivalents, End of Period	$	11,389		$	11,235		$	8,727		$	9,603

Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	$	209		$	309		$	268		$	517
Cash Paid During the Period for Income Taxes, Net of Refunds	$	1,689		$	251		$	2,243		$	250

See Notes to condensed consolidated financial statements (unaudited).

Table of Contents

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries.

Our business consists of 2 segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel

, TrojanLabel

and GetLabels

™

brand names. The T&M segment includes our line of aerospace flight deck printers and test and measurement data acquisition systems sold under the AstroNova

brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers, high-volume presses and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, that allow customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats.

Our Product Identification products are sold by direct field salespersons as well as independent dealers and representatives, while our Test & Measurement products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in Product Identification products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.

Unless otherwise indicated, references to “AstroNova”, “we,” “our,” and “us” in this Quarterly Report on

Form 10-Q

refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information, in context of the unknown future impacts of the continuing

COVID-19

pandemic, using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, accrued expenses, self-insurance liability accrual, useful lives of sales contract costs and intangibles, and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope and severity of the

COVID-19

pandemic. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

Table of Contents

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Note 2 – Summary of Significant Accounting Policies Update

The accounting polices used in preparing the condensed consolidated financial statements in this Form

10-Q

are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the ~~FASB~~Financial Accounting Standards Board issued ~~an ASU~~Accounting Standards Update (“ASU”)

2019-12,

“Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU

2019-12

is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. We adopted ASU

2019-12

for the period beginning February 1, 2021. The adoption of this guidance did not have a material impact on our consolidated financial statements and accompanying disclosures.

No other new accounting pronouncements, issued or effective during the ~~six~~nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:


	Three Months Ended				Six Months Ended				Three Months Ended				Nine Months Ended
(In thousands)	July 31, 2021		August 1 , 20 20		July 31, 2021		August 1, 2020		October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020
United States	$	17,181	$	17,866	$	33,874	$	37,655	$	17,280	$	16,788	$	51,154	$	54,442
Europe		7,826		6,314		16,425		13,764		7,163		7,081		23,588		20,845
Canada		1,491		1,452		3,037		2,880		1,724		1,273		4,761		4,154
Asia		1,964		831		3,049		1,841		1,473		1,209		4,523		3,050
Central and South America		995		914		1,756		1,868		814		1,233		2,569		3,101
Other		388		281		782		570		403		433		1,185		1,003

Total Revenue	$	29,845	$	27,658	$	58,923	$	58,578	$	28,857	$	28,017	$	87,780	$	86,595

Major product types:


	Three Months Ended				Six Months Ended				Three Months Ended				Nine Months Ended
(In thousands)	July 31, 2021		August 1, 2020		July 31, 2021		August 1, 2020		October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020
Hardware	$	7,878	$	8,439	$	15,525	$	17,354	$	7,622	$	7,667	$	23,147	$	25,021
Supplies		18,678		17,140		36,888		36,258		18,055		17,996		54,944		54,254
Service and Other		3,289		2,079		6,510		4,966		3,180		2,354		9,689		7,320

Total Revenue	$	29,845	$	27,658	$	58,923	$	58,578	$	28,857	$	28,017	$	87,780	$	86,595

Table of Contents

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were ~~$324,000~~$284,000 and $285,000

at ~~July 31,~~October 30, 2021 and January 31, ~~202~~

,2021, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The decrease in the deferred revenue balance during the ~~six~~nine months ended ~~July 31,~~October 30, 2021 is primarily due ~~to cash payments received in advance of satisfying performance obligations in the current period, offset by $202,000~~

$254,000

of revenue recognized during the period that was included in the deferred revenue balance at January 31, ~~2021.~~2021, offset by cash payments received in advance of satisfying performance obligations in the current period.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a

customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. In the second quarter of the current year, we extended the remaining useful life of these deferred costs from 6 years to 20 years and changed the amortization method from units sold to the straight-line method.

We believe these changes, based on the life of the aircraft under the applicable sales contracts, appropriately reflects a more systematic and rational approach. This change is being treated as a change in accounting estimate that is ~~effected~~

ffected by a change in accounting principle. The impact on net income was immaterial for the ~~six month~~

nine-month

period ended ~~July 31,~~October 30, 2021. The balance of these contract assets at January 31, 2021 was

~~$0.8~~

$0.9 million and

in the second quarter of the current year, we incurred an additional $0.4

million in contract costs which will be amortized over

20 years. We amortized ~~$26,000~~$43,000 of direct costs for the ~~six~~nine months ended ~~July 31,~~October 30, 2021, and the balance of deferred incremental direct costs net of accumulated amortization at ~~July 31,~~October 30, 2021 was $1.3

~~milli~~

million of which $0.1

million is reported in other current assets and $

~~1.2~~

$1.2 million is reported in other assets in the accompanying condensed consolidated balance sheet.

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

Three Months Ended

Six Months Ended


July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

Weighted Average Common Shares Outstanding – Basic
   7,208,834    7,105,241    7,176,940    7,089,169
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units
   119,724    17,354    120,178    24,359








Weighted Average Common Shares Outstanding – Diluted
   7,328,558    7,122,595    7,297,118    7,113,528


	Three Months Ended				Nine Months Ended
	October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020

Weighted Average Common Shares Outstanding – Basic		7,234,045		7,120,286		7,196,066		7,099,505
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		0		65,199		128,437		37,973

Weighted Average Common Shares Outstanding – Diluted		7,234,045		7,185,485		7,324,503		7,137,478

For the three ~~and six~~ months ended ~~July 31,~~October 30, 2021, the Company had weighted average common stock equivalent shares outstanding of 144,955 that could potentially dilute earnings per share in future periods that were excluded from the computation of diluted EPS because their effect would have been anti-dilutive given the net loss during the period. For the

three and nine months ended October 30, 2021, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding

of 189,827 and ~~484,748~~

362,935

respectively. For the three and ~~six~~nine months ended ~~August 1,~~October 31, 2020, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of

~~901,962~~ 689,157 and ~~912,508~~

892,868

respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

101

Table of Contents

Note 5 – Intangible Assets

Intangible assets are as follows:

July 31, 2021

January 31, 2021

(In thousands)

Gross
Carrying
Amount

Accumulated
Amortization

Currency
Translation
Adjustment

Net
Carrying
Amount

Gross
Carrying
Amount

Accumulated
Amortization

Currency
Translation
Adjustment

Net
Carrying
Amount

Miltope:

Customer Contract Relationships
   $ 3,100    $ (2,399 ) $ —      $ 701    $ 3,100    $ (2,284 ) $ —      $ 816
RITEC:

Customer Contract Relationships
   2,830    (1,523 ) —      1,307    2,830    (1,423 ) —      1,407
TrojanLabel:

Existing Technology
   2,327    (1,590 ) 174    911    2,327    (1,405 ) 196    1,118
Distributor Relations
   937    (448 ) 76    565    937    (396 ) 89    630
Honeywell:

Customer Contract Relationships
   27,243    (10,653 ) —      16,590    27,243    (9,712 ) —      17,531












Intangible Assets, net
   $ 36,437    $ (16,613 ) $ 250    $ 20,074    $ 36,437    $ (15,220 ) $ 285    $ 21,502


	October 30, 2021									January 31, 2021
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount

Miltope:
Customer Contract Relationships	$	3,100	$	(2,457	)	$	—	$	643	$	3,100	$	(2,284	)	$	—	$	816
RITEC:
Customer Contract Relationships		2,830		(1,540	)		—		1,290		2,830		(1,423	)		—		1,407
TrojanLabel:
Existing Technology		2,327		(1,680	)		151		798		2,327		(1,405	)		196		1,118
Distributor Relations		937		(473	)		62		526		937		(396	)		89		630
Honeywell:
Customer Contract Relationships		27,243		(10,863	)		—		16,380		27,243		(9,712	)		—		17,531

Intangible Assets, net	$	36,437	$	(17,013	)	$	213	$	19,637	$	36,437	$	(15,220	)	$	285	$	21,502

In the second quarter of the current year, we extended the remaining useful life of the customer contract relationship intangibles for Honeywell International, Inc. (“Honeywell”) from

6 years to 20 years and for the

RITEC intangibles we changed the amortization method which was based on revenue with a remaining life

of 4 years to the straight-line method with a 20

~~-year~~ 20-year

remaining life. We believe these changes, based on the life of the aircraft related to these intangibles, appropriately reflects a more systematic and rational approach to distributing the cost of these intangibles over their useful lives. The change in the amortization of the Honeywell customer contract relationship intangibles is being treated as a change in accounting estimate and the change in the amortization of the RITEC customer contract relationship intangibles is being treated as a change in accounting estimate that is effected by a change in accounting principle. The changes in amortization resulted in a

~~$587,000~~$1.2 million decrease in amortization expense and a ~~$587,000, ($553,000 net of tax or $0.08~~$1.2

~~per diluted share)~~million, increase to net income for

the ~~six-month~~nine-month period ended ~~July 31,~~October 30, 2021.

There were 0 impairments to intangible assets during the periods ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020. With respect to the acquired intangibles included in the table above, amortization expense of $0.4 million and $1.0 million has been included in the condensed consolidated statements of income for the three months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020, respectively. Amortization expense of ~~$1.4~~$1.8 million and ~~$2.1~~ $3.1

million related to the above acquired intangibles has been included in the accompanying condensed consolidated statement of income for the ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020, respectively.

Table of Contents

Estimated amortization expense for the next five fiscal years is as follows:


(In thousands)	Remaining 2022		2023		2024		2025		2026		Remaining 2022		2023		2024		2025		2026
Estimated amortization expense	$	805	$	1,641	$	1,702	$	1,010	$	1,010	$	401	$	1,637	$	1,699	$	1,009	$	1,009

Note 6 – Inventories

Inventories are stated at the lower of cost

(first-in,

first-out)

~~and~~or net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:

(In thousands)

July 31, 2021

January 31, 2021

Materials and Supplies
   $ 19,609    $ 20,265
Work-In-Process
   2,205    2,076
Finished Goods
   15,871    16,371




   37,685    38,712
Inventory Reserve
   (8,595 )    (8,652 )




   $ 29,090    $ 30,060


(In thousands)	October 30, 2021			January 31, 2021
Materials and Supplies	$	21,526		$	20,265
Work-In-Process		2,061			2,076
Finished Goods		16,928			16,371

		40,515			38,712
Inventory Reserve		(8,854	)		(8,652	)

	$	31,661		$	30,060

111

Table of Contents

Note 7—Property, Plant and Equipment

Property, plant and equipment consists of the following:


	October 30,			January 31,
	2021			2021
(In thousands)
Land and Land Improvement	$	1,004		$	1,004
Buildings and Leasehold Improvements		12,635			12,642
Machinery and Equipment		23,305			23,346
Computer Equipment and Software		13,680			13,847

Gross Property, Plant and Equipment		50,624			50,839
Accumulated Depreciation		(38,950	)		(38,828	)

Net Property Plant and Equipment	$	11,674		$	12,011

Depreciation expense on property, plant and equipment was $0.4 million and $1.2 million for the three and nine months

ended October 30, 2021. Depreciation expense on property, plant and equipment was $1.5 million and $0.4 million for the three and nine months ended October 31, 2020.

During the quarter ended October 30, 2021, we wrote-off our Oracle EnterpriseOne enterprise resource planning (“ERP”) system in anticipation of the full implementation of our new global ERP system which was effective at the beginning of the fourth quarter of the current year. The book value and related accumulated depreciation of the Oracle EnterpriseOne ERP system along with the balance of the related prepaid service and maintenance contracts have been removed from the accompanying condensed consolidated balance sheet at October 30, 2021 and we have recorded a net loss on the disposal of $

696,000,

which is included in other income (expense) in the accompanying condensed consolidated income statement for the three and nine months ended October 30, 2021.

Table of Contents

Note 78 – Credit Agreement and Debt

Credit Agreement

On March 24, 2021, we entered into a First Amendment to Credit Agreement (the “Amendment”) to our Amended & Restated Credit Agreement (the “A&R Credit Agreement,” as amended by the Amendment; the “Amended Credit Agreement”) with Bank of America, N.A., as lender (the “Lender”), and our subsidiaries, ANI ApS and TrojanLabel. The A&R Credit Agreement, which we entered into on July, 30, 2020, amended and restated the Credit Agreement dated as of February 28, 2017 (the “Prior Credit Agreement”) by and among us, ANI ApS, TrojanLabel and the Lender. Immediately prior to the closing of the Amendment, we repaid $2.6 million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $10.0 million and 0 amount drawn and outstanding under the revolving credit facility under the A&R Credit Agreement.

The Amended Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million, and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amendment, we borrowed the entire $10.0 million term loan which was used to refinance, in full, the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

At ~~July 31,~~October 30, 2021, there is 0 balance outstanding on the revolving line of credit and the entire $22.5 million is available for borrowing. There was 0

interest incurred for the ~~three~~three- and ~~six month~~nine-month period ended ~~July 31,~~October 30, 2021 and ~~$94,000~~$

22,000 and ~~$166,000~~$188,000

of interest was incurred on this obligation and included in interest expense in the accompanying condensed consolidated income statement for the ~~three~~three- and ~~six month~~nine-month periods ended ~~August 1,~~October 31, 2020, respectively.

The Amended Credit Agreement requires that the term loan be paid as follows: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2021 through January 31, 2022 is $187,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2022 through January 31, 2023 is $250,000; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2023 through January 31, 2025 is $312,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2025 and July 31, 2025 is $500,000; and the entire remaining principal balance of the term loan is required to be paid on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

Table of Contents

The Amended Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10.0 million, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

Lender’s

publicly announced prime rate, (iii) the LIBOR Rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30% based on our consolidated leverage ratio. During the quarter ended ~~July 31,~~October 30, 2021, we ~~paid $30,125~~incurred $8,300 in commitment fees on the undrawn portion of our revolving credit facility, which is included in interest expense in the accompanying condensed consolidated income statement.

As under the A&R Credit Agreement, the loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

121

Table of Contents

We must comply with various customary financial and

non-financial

covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Amendment.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving

credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)

July 31, 2021

January 31, 2021

USD Term Loan (2.60% as of July 31, 2021); maturity date of September 30, 2025
   $ 9,625    $ —
USD Term Loan (4.65% as of January 31, 2021)
   —      12,576





$
9,625    $ 12,576
Debt Issuance Costs, net of accumulated amortization
   (109 )    (141 )
Current Portion of Term Loans
   (875 )    (5,326 )




Long-Term Debt
   $ 8,641    $ 7,109


(In thousands)	October 30, 2021			January 31, 2021

USD Term Loan (2.35% as of October 30, 2021); maturity date of September 30, 2025	$	9,438		$	—
USD Term Loan (4.65% as of January 31, 2021)		—			12,576

	$	9,438		$	12,576
Debt Issuance Costs, net of accumulated amortization		(103	)		(141	)
Current Portion of Term Loans		(938	)		(5,326	)

Long-Term Debt	$	8,397		$	7,109

During the three and ~~six~~nine months ended ~~July 31,~~October 30, 2021, we recognized ~~$65,000~~$50,000 and ~~$179,000~~$230,000 of

interest expense on debt, respectively, which was included in interest expense in the accompanying condensed consolidated income statement. During the three and ~~six~~nine months ended ~~August 1,~~October 31, 2020, we recognized

~~$73,000~~ $159,000 and ~~$152,000~~$312,000 of interest expense on debt, respectively, which was included in interest expense in the accompanying condensed consolidated income statement.

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of ~~July 31,~~October 30, 2021 is as follows:


(In thousands)
Fiscal 2022, remainder	$	375	$	188
Fiscal 2023		1,000		1,000
Fiscal 2024		1,000		1,000
Fiscal 2025		1,250		1,250
Fiscal 2026		6,000		6,000

	$ 9,625		$	9,438

Note 89 – Paycheck Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4

million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020, ~~(the “PPP Flexibility Act”)~~ which was enacted on June 5, 2020.

131

Table of Contents

The PPP Loan,

~~which~~

~~would have been set~~ originally scheduled to mature on

May 6, 2022,

is was unsecured and ~~bears~~bore interest at a rate of

1.0%

per annum, accruing from the loan ~~date, and is payable monthly~~

.date. NaN

payments

were due on the PPP Loan until the date on which the lender ~~determines~~determined the amount of the PPP Loan that is eligible for forgiveness. The PPP Loan iswas classified as long-term debt – PPP Loan in the condensed consolidated balance sheet until forgiveness iswas made.

On June 15, 2021,

Greenwood

notified us that the SBA approved our application for forgiveness of the entire $

~~4.4~~

$4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a

result,

, in the second quarter of fiscal 2022, we recorded a $4.5 million gain on extinguishment of debt, which is included in the accompanying condensed consolidated income statement for the ~~three and six~~nine months ended ~~July 31,2021.~~October 30, 2021.

Note 910 – Derivative Financial Instruments and Risk Management

In 2017, we entered into a cross-currency interest rate

swap

to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with our variable rate term loan borrowing. Both swaps were designated as cash flow hedges of floating-rate borrowings.

Our cross-currency interest rate swap agreement effectively modified our exposure to interest rate risk and foreign currency exchange rate risk by converting our floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement effectively modified our exposure to interest rate risk by effectively converting our floating-rate term-loan debt to fixed-rate debt, thus reducing the impact of interest-rate changes on future interest expense. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for ~~fixed rate~~fixed-rate payments in U.S. dollars over the life of the term loan.

As a direct result of the terms of the Lender’s conditions for entry into the A&R Credit Agreement, on July 30, 2020, we terminated these two swaps. The terms of the A&R Credit Agreement caused those swaps to cease to be effective hedges of the underlying exposures. The termination of the swaps was contracted immediately prior to the end of the second quarter of fiscal 2021 at a cash cost of approximately $0.7 million, which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $58,000 in accumulated other comprehensive loss related to the cross-currency interest rate swap was reclassified into earnings as the forecasted foreign currency interest payments will not occur. The $ 0.2 million balance remaining ~~balance~~ in accumulated other comprehensive loss related to the interest rate swap ~~of $ 0.2 million~~ is being amortized into earnings through the original term of the hedge relationship, as the underlying floating interest rate debt still exists.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three and ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020:

Three Months Ended


Amount of Gain (Loss)
Recognized in OCI
on Derivative

Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into
Income

Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income

Cash Flow Hedge
(In thousands)

July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

Swap contracts
   $ —      $ (290 ) Other Income (Expense )

$ (20 ) $ (297 )


	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 30, 2021		October 31, 2020			October 30, 2021			October 31, 2020

Swap contracts	$	—	$	0	Other Income (Expense)	$	(20	)	$	(20	)

Table of Contents

Six Months Ended


Amount of Gain (Loss)
Recognized in OCI
on Derivative

Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into Income

Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income

Cash Flow Hedge
(In thousands)

July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

Swap contracts
   $ —      $ (340)

Other Income (Expense) $ (40)

$ (248)

~~At July 31,~~


	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative					Location of Gain (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 30, 2021		October 31, 2020				October 30, 2021			October 31, 2020
Swap contracts	$	—	$	(340	)	Other Income (Expense)	$	(60	)	$	(268	)

As of October 30, 2021, we

expect

to reclassify approximately $0.1 million of net losses on the frozen OCI balance associated with the terminated interest rate swap from accumulated other comprehensive loss to earnings during the next 12 months due to the payment of variable interest associated with the floating

interest

rate debt.

Note 1011 – Employee Retention Credit

The CARES Act provides an employee retention

credit

(“ERC”)

that is a refundable tax credit against certain employer taxes. On December 27, 2020, Congress enacted the Taxpayer Certainty and Disaster Tax Relief Act of 2020, which amended and extended ERC availability under Section 2301 of the CARES Act. Before the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we were ineligible for the ERC because we

received

the PPP Loan. Following enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we and other businesses that received loans under that program became retroactively eligible for the ERC.

As a result of the foregoing legislation, we are eligible to claim a refundable tax credit against the employer share of Social Security taxes equal to seventy percent (70%) of the qualified wages that we paid to our employees between December 31, 2020 and June 30, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum ERC per employee of $7,000 per calendar quarter in 2021.

Since there is no US GAAP guidance for

for-profit

business entities that receive government assistance that is not in the form of a loan, an income tax credit or revenue from a contract with a customer, we determined the appropriate accounting treatment by analogy to other guidance. We accounted for the employee retention credit by analogy to International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, of International Financial Reporting Standards (IFRS). Under an IAS 20 analogy, a business entity would recognize the credit on a systematic basis over the periods in which the entity recognizes the payroll expenses for which the grant (i.e., tax credit) is intended to compensate when there is reasonable assurance (i.e., it is probable) that the entity will comply with any conditions attached to the grant and the grant (i.e., tax credit) will be received, accordingly, we recognized the employee retention credit in the income statement captions from which the employee taxes were originally incurred and offset the receivable in prepaid expenses and other current assets.

We evaluated our eligibility for the ERC in the second quarter of calendar year 2021. In order to qualify for the ERC, we needed to experience a 20% reduction in gross receipts from either (1) the same quarter in calendar year 2019 or (2) the immediately preceding quarter to the corresponding calendar quarter in 2019. We determined that we qualified for the employee retention credit under the first scenario for wages paid in calendar year 2020 and the first calendar quarter of 2021. ~~We are amending~~In the second quarter of the current year, we amended certain payroll tax filing

and ~~will apply~~applied for a refund of $3.1

million. We ~~have~~ recorded ~~this amount as~~ a receivable in the second quarter of the current year within ~~the~~ prepaid expenses and other current assets in the condensed consolidated balance ~~sheet~~sheet. Such amount remains outstanding as of ~~July 31,~~October 30, 2021.

~~The~~In the second quarter of the current year, the $3.1 million of ERCs was recognized as a reduction in employer payroll taxes and allocated to the financial statement captions from which the employee’s taxes were originally incurred. As a result, we recorded a reduction in expenses of $1.7 million in cost of revenue, $0.8 million in selling and marketing, $0.3 million in research and development and $0.3 million in general and administrative which is reflected in the accompanying condensed consolidated income statement for the ~~three and six month periods~~

nine-month

period ended ~~July 31,~~October 30, 2021.

1519

Table of Contents

Note 1112 – Royalty Obligation

In fiscal 2018, we entered

into

an Asset Purchase and License Agreement with Honeywell to acquire an exclusive, perpetual, world-wide

license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years, based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated

after-tax

cost of debt for similar companies. As of ~~July 31,~~October 30, 2021, we had paid an aggregate of ~~$6.5~~$7.0 million of the guaranteed minimum royalty obligation. At ~~July 31,~~October 30, 2021, the current portion of the outstanding guaranteed minimum royalty obligation of $2.0 million is to be paid over the next twelve months and is reported as a current liability,

and the remainder of ~~$5.3~~$4.8 million is reported as a long-term liability on our condensed consolidated balance sheet. We incurred ~~$24,000~~$0.2

million in

excess royalty expense for the ~~three and six month periods~~

nine-month

period ended ~~July 31,~~October 30, 2021,

which is included in cost of revenue in our consolidated statements of income. A total of $0.2 million in excess royalties was paid in the ~~first quarter of the~~ current fiscal year,

and there are ~~$25,000~~$0.2 million in excess royalty payables due as a

result

of this agreement for the period ended ~~July 31,~~October 30, 2021.

Note 1213 – Leases

We enter into

lease

contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of one to six years, some of which include

options to extend the lease term for periods of up to five years

when it is reasonably certain that we will exercise such options.

Balance sheet and other information

to our leases is as follows:

Operating Leases
(In thousands)

Balance Sheet Classification

July 31,
2021

January 31,
2021

Lease Assets
   Right of Use Assets    $ 1,209    $ 1,389
Lease Liabilities
–
Current
   Other Liabilities and Accrued Expenses    351    372
Lease Liabilities
–
Long Term
   Lease Liabilities    907    1,065


Operating Leases (In thousands)	Balance Sheet Classification	October 30, 2021		January 31, 2021

Lease Assets	Right of Use Assets	$	1,106	$	1,389
Lease Liabilities – Current	Other Liabilities and Accrued Expenses		329		372
Lease Liabilities – Long Term	Lease Liabilities		826		1,065

Lease cost information is as follows:


		Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification	October 30, 2021		October 30, 2021
Operating Lease Costs	General and Administrative Expense	$	125	$	386

Three Months Ended

Six Months Ended

Operating Leases
(In thousands)

Statement of Income Classification

July 31,
2021

July 31,
2021

Operating Lease Costs
General and Administrative Expense    $ 124    $ 260

Three Months Ended

Six Months Ended

Operating Leases
(In thousands)

Statement of Income Classification

August 1,
2020

August 1,
2020

Operating Lease Costs
   General and Administrative Expense    $ 122    $ 242


		Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification	October 31, 2020		October 31, 2020
Operating Lease Costs	General and Administrative Expense	$	120	$	362

Maturities of operating lease liabilities are as follows:


(In thousands)	July 31, 2021			October 31, 2021
2022, remaining	$	185		$	92
2023		314			309
2024		287			282
2025		180			176
2026		159			156
Thereafter		265			257

Total Lease Payments		1,390			1,272
Less: Imputed Interest		(132	)		(117	)

Total Lease Liabilities	$	1,258		$	1,155

As of ~~July 31,~~October 30, 2021, the weighted-average remaining lease term and

~~term~~

~~and~~ weighted-average discount rate for our operating leases are ~~4.9~~4.7 years and 4.0%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Table of Contents

Supplemental cash flow information related to leases is as follows:


	Three Months Ended		Six Months Ended		Three Months Ended		Nine Months Ended
(In thousands)	July 31, 2021		July 31, 2021		October 30, 2021		October 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	93	$	185	$	85	$	285


	Three Months Ended		Six Months Ended		Three Months Ended		Nine Months Ended
(In thousands)	August 1, 2020		August 1, 2020		October 31, 2020		October 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	125	$	231	$	102	$	333

Note 1314 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total			Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2021	$	(275	)	$	(109	)	$	(384	)	$	(275	)	$	(109	)	$	(384	)
Other Comprehensive Loss before reclassification		(429	)		—			(429	)		(839	)		—			(839	)
Amounts reclassified from AOCL to Earnings		—			31			31			—			47			47

Other Comprehensive Income (Loss)		(429	)		31			(398	)		(839	)		47			(792	)

Balance at July 31, 2021	$	(704	)	$	(78	)	$	(782	)
Balance at October 30, 2021										$	(1,114	)	$	(62	)	$	(1,176	)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German, Danish and Shanghai subsidiaries.

Note 1415 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options,

non-qualified

stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were ~~133,836~~132,503 unvested RSUs; 65,167 unvested PSUs; 20,410 unvested RSAs and options to purchase an aggregate of 135,500 shares outstanding as of ~~July 31,~~October 30, 2021.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of ~~July 31,~~October 30, 2021, options to purchase an aggregate of ~~326,968~~326,468 shares were outstanding under the 2007 Plan and 3,750 unvested shares of restricted stock and options to purchase an aggregate of ~~141,175~~141,000 shares were outstanding under the 2015 Plan.

We also have a

Non-Employee

Director Annual Compensation Program (the “Program”), under which each of our

non-employee

directors automatically receives a grant of restricted stock on the date of their

re-election

to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 20

2022 is $60,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

Table of Contents

Share-based compensation expense was recognized as follows:


	Three Months Ended				Six Months Ended				Three Months Ended				Nine Months Ended
(In thousands)	July 31, 2021		August 1, 2020		July 31, 2021		August 1, 2020		October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020
Stock Options	$	57	$	131	$	162	$	264	$	25	$	126	$	187	$	390
Restricted Stock Awards and Restricted Stock Units		408		465		778		822		369		462		1,147		1,284
Employee Stock Purchase Plan		4		5		7		10		4		3		11		13

Total	$	469	$	601	$	947	$	1,096	$	398	$	591	$	1,345	$	1,687

Stock Options

There were 0 stock options granted during the ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020.

Aggregated information regarding stock option activity for the ~~six~~nine months ended ~~July 31,~~October 30, 2021 is summarized below:


	Number of Options			Weighted Average Exercise Price		Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2021		622,083		$	14.63		622,083		$	14.63
Granted		0			0		0			0
Exercised		(4,425	)		9.57		(4,925	)		9.42
Forfeited		(14,015	)		14.96		(14,190	)		15.00
Canceled		0			0		0			0

Outstanding at July 31, 2021		603,643		$	14.66
Outstanding at October 30, 2021							602,968		$	14.66

Set forth below is a summary of options outstanding at ~~July 31,~~October 30, 2021:


Outstanding	Outstanding							Exercisable						Outstanding							Exercisable
Range of Exercise prices		Number of Option s		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Option s		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life			Number of Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Options		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$5.00-10.00			37,244	$	7.97		1.0		37,244	$	7.97		1.0			36,711	$	7.97		1.0		36,744	$	7.97		1.0
$10.01-15.00			348,649	$	13.62		4.4		336,649	$	13.61		4.3			348,649	$	13.62		4.1		336,649	$	13.61		4.0
$15.01-20.00			217,750	$	17.47		6.3		210,875	$	17.44		6.3			217,575	$	17.47		6.0		210,875	$	17.44		6.1

			603,643	$	14.66		4.9		584,768	$	14.63		4.8			602,968	$	14.66		4.6		584,268	$	14.63		4.6

As of ~~July 31,~~October 30, 2021, there was approximately ~~$59,000~~$32,000 of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately ~~0.6~~0.4 years.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU and RSA activity for the six months ended ~~July 31,~~October 30, 2021 is summarized below:

RSAs & RSUs

Weighted Average
Grant Date Fair Value

Outstanding at January 31, 2021
   197,413 $ 9.96
Granted
   147,006 14.43
Vested
   (121,256 ) 10.30


Outstanding at July 31, 2021    223,163 $ 12.72


	RSAs & RSUs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2021		197,413		$	9.96
Granted		147,006			14.43
Vested		(121,689	)		10.30
Forfeited		(900	)		14.26

Outstanding at October 30, 2021		221,830		$	12.73

As of July 31, 2021, there was approximately ~~$2.5~~$2.1 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of ~~1.0~~0.9 year.

Table of Contents

Employee Stock Purchase Plan

We have an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020, there were ~~3,899~~5,684 and ~~8,851~~12,098 shares, respectively, purchased under this plan. As of ~~July 31,~~October 30, 2021, ~~6,475~~4,690 shares remain available for purchase under our Employee Stock Purchase Plan.

Note 1516 – Income Taxes

Our effective tax rates for the period are as follows:


	Three Months Ended			Six Months Ended			Three Months Ended			Nine Months Ended
Fiscal 2022		9.1	%		5.8	%		29.0	%		4.0	%
Fiscal 2021		99.4	%		48.6	%		160.0	%		45.9	%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted

pre-tax

income and facts known at that time. The estimated annual effective tax rate is applied to the

year-to-date

pre-tax

income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended ~~July 31,~~October 30, 2021, we recognized an income tax ~~expense of~~

~~$0.7~~

~~million. The effective tax rate in this period was directly impacted by a~~

~~$1.1~~

~~million tax~~ benefit ~~from the forgiveness of the PPP Loan, a $~~

~~0.1~~

~~million tax benefit arising from a windfall related to our stock compensation and a~~

~~$32,000~~

tax benefit related to return to provision adjustments from foreign tax returns filed in the quarter. The PPP Loan forgiveness recognized during the three months ended July 31, 2021, is excluded from federal taxable income under Section 1106(i) of the CARES Act. During the three months ended August 1, 2020, we recognized an income tax expense of approximately

~~$0.5~~

~~million.~~ $174,000. The effective tax rate in this period was directly impacted by a significant ~~increase~~decrease in forecasted operating results for our fiscal ~~year~~2022 as compared to operating results forecasted at the end of our second quarter of fiscal 2022. During the three months ended October 31, 2020, we recognized an income tax benefit of approximately $32,000. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2021 as compared to operating results forecasted at the end of our ~~first~~second quarter of fiscal ~~2021, a~~2021.

~~$0.1~~

~~million expense arising from a shortfall related to our stock and a $~~

~~0.1~~

~~million expense related to return to provision adjustments from foreign tax returns filed in the quarter.~~

During the ~~six~~nine months ended ~~July 31,~~October 30, 2021, we recognized an income tax expense of

~~$0.5~~

~~million.~~approximately $297,000. The effective tax rate in this period was directly impacted by a

~~$1.1~~

significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our second quarter of fiscal 2022, a $1.1 million tax benefit from the forgiveness of the PPP ~~loan,~~

oan, a $

~~0.1~~

$0.1 million tax benefit arising from windfall tax expense related to our stock, a

~~$32,000~~

$30,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the year, and a

~~$0.3~~

$0.3 million tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions. The PPP ~~loan~~

oan forgiveness recognized during the six months ended
July 31, 2021, is excluded from taxable income under Section 1106(i) of the CARES Act. During the ~~six~~nine months ended ~~August 1,~~October 31, 2020, we recognized
an income tax expense of approximately

~~$0.4~~

~~million.~~$379,000. The effective tax rate in this period was directly impacted by a significant ~~increase~~decrease in forecasted operating results for our fiscal ~~year~~ 2021 as compared to operating results forecasted at the end of our ~~first~~second quarter of fiscal ~~year~~ 2021, a

~~$0.1~~

~~million~~$118,000 expense arising from shortfall tax expense related to our stock, a

~~$0.1~~

~~million~~$79,000 expense related to return to provision adjustments from foreign tax returns filed in the year and a

~~$0.1~~

~~million~~$78,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions.

We maintain a valuation allowance on some of our deferred tax assets in certain jurisdictions. A valuation allowance is required when, based upon an assessment of various factors, including recent operating loss history, anticipated future earnings, and prudent and reasonable tax planning strategies, it is more likely than not that some portion of the deferred tax assets will not be realized.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of ~~July 31,~~October 30, 2021, our cumulative unrecognized tax benefits totaled $221,000 compared to $384,000

as of
January 31, ~~2020.~~2021. We established unrecognized tax benefits for certain positions taken on the fiscal year 2021 Canadian tax return. There

were 0 other developments affecting unrecognized tax benefits during the quarter ended ~~July 31,~~October 30, 2021.

192

Table of Contents

Note 1617 – Segment Information

We report two segments: Product Identification (“PI”) and Test & Measurement (“T&M”). We evaluate segment performance based on the segment profit (loss) before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	October 30, 2021		October 31, 2020		October 30, 2021			October 31, 2020			October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020
Product Identification	$	21,928	$	22,898	$	1,818		$	3,521		$	68,519	$	66,907	$	8,952	$	9,813
T&M		6,929		5,119		842			(751	)		19,261		19,688		2,902		(1,314	)

Total	$	28,857	$	28,017		2,660			2,770		$	87,780	$	86,595		11,854		8,499

Corporate Expenses						2,364			2,353							7,372		7,214

Operating Income						296			417							4,482		1,285
Other Income (Expense), Net						(895	)		(437	)						3,002		(459	)

Income (Loss) Before Income Taxes						(599	)		(20	)						7,484		826
Income Tax Provision (Benefit)						(174	)		(32	)						297		379

Net Income (Loss)					$	(425	)	$	12						$	7,187	$	447

Three Months Ended

Six Months Ended


Revenue

Segment Operating Profit
(Loss)

Revenue

Segment Operating Profit
(Loss)

(In thousands)

July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

July 31,
2021

August 1,
2020

Product Identification
   $ 23,492    $ 21,629    $ 4,406    $ 3,146 $ 46,590    $ 44,009    $ 7,134    $ 6,292
T&M
   6,353    6,029    1,710    (407 ) 12,333    14,569    2,060    (563 )














Total
   $ 29,845    $ 27,658    6,116    2,739 $ 58,923    $ 58,578    9,194    5,729









Corporate Expenses
      2,664    2,535    5,008    4,861








Operating Income
      3,452    204    4,186    868
Other Income (Expense), Net
      4,266    328    3,897    (23 )








Income Before Income Taxes
      7,718    532    8,083    845
Income Tax Provision
      699    529    471    411








Net Income
      $ 7,019    $ 3    $ 7,612    $ 434

024

Table of Contents

Note 1718 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	July 31, 2021										October 30, 2021
	Fair Value Measurement										Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value		Level 1		Level 2		Level 3		Total		Carrying Value

Long-Term debt and related current maturities	$	—	$	—	$	9,633	$	9,633	$	9,625	$	—	$	—	$	9,443	$	9,443	$	9,438

January 31, 2021


Fair Value Measurement

(In thousands)

Level 1

Level 2

Level 3

Total

Carrying
Value

Long-Term debt and related current maturities
   $ —      $ —      $ 12,586    $ 12,586    $ 12,576


	January 31, 2021
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	12,586	$	12,586	$	12,576

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with our condensed consolidated financial statements included elsewhere herein and our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

We are a multinational enterprise that leverages our proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. We organize our structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. We market and sell our products and services through the following two segments:

Product Identification (“PI”) – offers color and monochromatic digital label printers,

direct-to-package

printers and custom OEM printers. PI also provides software to design, manage and print labeling and packaging images locally and across networked printing systems, as well as all related printing supplies such as pressure sensitive labels, tags, inks, toners and thermal transfer ribbons used by digital printers. PI also provides

on-site

and remote service, spare parts and various service contracts.

Test and Measurement (“T&M”) – offers a suite of products and services that acquire data from local and networked data streams and sensors as well as wired and wireless networks. The T&M segment includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft including navigation maps, clearances, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Aerospace products also include aircraft networking systems for high-speed onboard data transfer. T&M also provides repairs, service and spare parts.

We market and sell our products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets. Our growth strategy centers on organic growth through product innovation made possible by research and development initiatives, as well as strategic acquisitions that fit into or complement existing core businesses.

Table of Contents

COVID-19

Update—Overview

Our business has been and likely will continue to be materially adversely affected by the global

COVID-19

pandemic. We operate in several regions of the world, with the largest concentration of team members in North America and Europe, and a smaller presence in Asia. Since the

COVID-19

pandemic began, we have monitored government recommendations and regulations in the areas where we operate and have made good faith efforts to comply with regulations, the best practices and recommendations issued by a variety of governmental health authorities and manufacturing industry organizations to which we belong. Throughout the pandemic we, and many other businesses and organizations with which we do business directly or which otherwise impact us, have taken steps to avoid or reduce infection as recommended by the public health authorities, including enabling teammates to work remotely from home and by limiting business travel and gatherings of people.

We made significant modifications to our normal operations because of the

COVID-19

pandemic, including requiring most

non-production

related team members to work remotely, at least part-time. As the result of declining infection rates in early 2021, and in response to guidance from local and national health authorities we relaxed some of our health-related workplace restrictions and practices. However, we anticipate reverting to more stringent workplace restrictions as the winter months near and the omicron variant emerges. Since the start of the pandemic, we have maintained most of the manufacturing operational capacity at our facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany. In the West Warwick and Canadian operations there were periods when a number of team members were unable to maintain their work schedules due to the effects of the pandemic, which resulted in reduced production capacity, longer order fulfillment lead times, and as a result, reduced revenues. Those impacts of the pandemic, to a large degree, have abated. We expect that our operations and modalities of

on-site

and remote work will be impacted permanently, as will our increased safety protocols and the other adaptations undertaken during the pandemic, but our practices and plans are still developing our plans and we cannot predict the result yet.

Vaccinations against the viruses that cause the COVID have become a prevalent but not universally accepted response to mitigating infection risk. Although ~~vaccine availability has expanded dramatically~~vaccination rates have continued to increase among our workforce and in the market economies where the majority of our revenues are derived, ~~this has not been true throughout the world, and even~~infection rates continue to surge in ~~our major market areas inoculation rates have not been sufficient to prevent another surge of infections~~various regions as more virulent strains of

COVID-19

have recently emerged. ~~Recommendations against gatherings of people and~~These case rates have led to further travel restrictions ~~between regions had loosened to varying degrees in some locations, but many have remained in place or have been reinstated, especially in Europe.~~imposed by various countries, and although not directly impacting our business activities, it is uncertain at this time what further travel restrictions may be imposed. It is impossible to determine the precise impact that the future course of the pandemic will have on our business. For example, some of the health practices that were instituted at the height of the pandemic are again being recommended, and in some cases

re-imposed.

At this point it is still unclear how the future course of the pandemic will evolve and how the public health authorities in the United States, Europe and Asia will respond. Accordingly, we cannot determine exactly how our own business practices and those of with whom we do business will respond as a result.

~~We made significant modifications to our normal operations because of the~~

~~COVID-19~~

~~pandemic, including requiring most~~

~~non-production~~

~~COVID-19~~

will cause us to impose additional restrictions. Since the start of the pandemic, we have maintained most of the manufacturing operational capacity at our facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany. In the West Warwick and Canadian operations there were periods when a number of team members were unable to maintain their work schedules due to the effects of the pandemic, which resulted in reduced production capacity, longer order fulfillment lead times, and as a result, reduced revenues. While those issues have abated to some degree, they are still impacting our operations. The extent to which the

~~COVID-19~~

pandemic continues to negatively impact our manufacturing production will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity

~~of COVID-19 variants,~~

~~the continued efficacy of vaccinations and the willingness of our employees and others to become vaccinated, among others. We expect that our operations and modalities of~~

~~on-site~~

and remote work will be impacted permanently, as will our increased safety protocols and the other adaptations undertaken during the pandemic, but we are still developing our plans and cannot predict the result yet.

Since the

COVID-19

pandemic began we have experienced some difficulties in obtaining raw materials and components for our products. Some of the structural dislocations in the global economy caused by the pandemic are prolonging these difficulties. ~~Thus far we have been able to successfully respond to these difficulties, but we~~We have had to incur additional costs to ~~do so,~~respond to these difficulties, including, for example, incurring expedited and express shipping ~~fees.~~fees (for example air rather than ocean freight.) These difficulties have impacted our efficiency, but we do not believe that they have yet materially impacted our relationships with our ~~customers.~~customers, despite some delayed shipments and product shortages

In the third quarter of fiscal year 2022 we experienced supply shortages that reduced shipments in that quarter by what we believe is approximately $1.5 million in revenue, but we expect to ship the affected items in the fourth quarter. We are currently monitoring the world-wide delays in transit time, as freight carriers are now experiencing significant delays in overseas shipments. We are addressing these issues through long range planning and ~~we are supplementing inventories as needed.~~procuring higher inventory on severely allocated items to help mitigate potential shortages whenever possible. We are also monitoring and reacting to extended lead times on active electronic components and utilizing several strategies, including blanket orders, vendor-bonded inventories, extended commitments to our supply base, and seeking alternative suppliers. Additionally, we have taken actions to maintain regular contact with our essential vendors and have increased our forecasting horizon for our products to help us better manage our supply ~~chain.~~chain, and in some cases, we are working with our vendors to help them procure components. Our strategies to counteract the impact of the pandemic and the supply chain dislocations that have developed have ~~tended to increase~~increased the amount of inventory we maintain to support our product sales. To date these additional inventory investments have been modest, but ~~because of the complexity of our manufacturing processes and diverse supply sources, it is impossible to isolate the precise impact by product line.~~we believe this need will increase if current market disruptions continue. We will continue to monitor our supply chain going forward and update our mitigation strategies as we determine appropriate. We are not able to predict how current supply chain difficulties will develop in the future, and if the steps we are taking are not effective, it could have a material adverse impact on our results of operations.

It is not possible at this time to estimate how the

COVID-19

pandemic or the consequences of its aftermath will continue to impact our business, customers, suppliers or other business partners, and the degree it will adversely change our operational capacity and the efficiency of our team members or affect our results of operations and financial condition.

Product Identification Update

The global

COVID-19

pandemic has negatively impacted sales of our Product Identification hardware products. This is primarily a result of the impact that travel restrictions have had on our sales efforts, as most customers historically have preferred

in-person

demonstrations of these printers at their production sites prior to placing orders with us and those visits have been restricted.

Additionally, the widespread cancellation of trade shows, which traditionally provided an effective forum for customers to consider our products, has also had an adverse impact on traditional methods of sales lead generation. While trade shows have begun to take place again, the future course of this trend is unclear as more ~~virulent~~transmissible virus variants become more widespread. We believe we have been able to partially offset these negative impacts by relying more heavily on various forms of digital advertising and internet-based marketing techniques to obtain sales, including remote video demonstrations and support.,. The degree to which we will be able to maintain or grow the level of hardware revenues through the changes we have made to our

go-to-market

strategies remains unclear. When the

COVID-19

pandemic abates, and as it becomes possible for our direct sales force and distributors to travel to visit customers and attend and present products at trade shows, it is likely that some reversion to those historical sales methods will occur. However, it is also likely that some of the

COVID-19

induced adaptations are also likely to become permanent. At this time, we do not know how that mix of sales strategies will evolve and how they will impact the results of operations for this segment.

Despite the pandemic, we believe that the diversified nature of our end markets and the relative concentration of business in consumer

non-durable

market related applications impart a greater degree of near- and longer-term stability to our Product Identification segment.

Test & Measurement Update

Our sales of flight deck printers for Boeing 737 aircraft have been severely impacted by the chain of events that occurred after two 737 MAX aircraft crashed. In March 2019, all major civil aviation authorities worldwide grounded the Boeing 737 MAX aircraft for safety reasons. In April 2019, Boeing reduced the number of 737 MAX aircraft produced per month from 52 to 42, and in January 2020, Boeing ceased production of the 737 MAX aircraft completely. On May 27, 2020, in anticipation of an eventual certification, Boeing announced that it would

re-start

production of 737 MAX aircrafts at low initial rates and gradually increase production in the future.

On August 3, 2020, the United States Federal Aviation Administration (the “FAA”) issued a notice of proposed rulemaking for a Boeing 737 MAX aircraft airworthiness directive, and on November 18, 2020 the FAA certified the model for return to service in the United States. On January 27, 2021, the European Union Aviation Safety Agency (EASA) approved the return to service of the Boeing 737 MAX aircraft in Europe. The exact timing of

re-certification

by other worldwide civil aviation authorities is unknown but we expect that most will permit a return to service later in 2021. Before each 737 MAX aircraft can return to commercial service, all civilian aviation authority agency certification requirements relevant to each carrier must be met. As these requirements vary, and can be quite extensive, the exact timing of the recertification and return to service of the 737 MAX fleet in each geographical area is unclear at this time and will depend on the ability of Boeing and each airline to complete the required steps.

Aircraft manufacturing rather than aircraft deliveries primarily drives demand for our airborne printer products. We experienced very low levels of 737 MAX aircraft new printer orders and shipments during the production halt, and now that Boeing is producing a small number of new aircrafts per month, our volume of 737 MAX aircraft printer orders and shipments has increased only modestly. The majority of our future 737 MAX printer sales volume will be tied to the pace of Boeing’s manufacturing dates and delivery schedules, and the pace of the recovery in their production rates is uncertain and will likely be prolonged. We believe that Boeing has already installed our printers in most of the airplanes that it has completed and that require our printers to be installed prior to delivery. Though we have noted that some airlines are now ordering new 737 MAX aircraft again, and we have seen slight increases in orders for future delivery, the effect of the improving outlook and its timing remains unknown. The precipitous decline in global air travel demand and resultant reduction in the number of flights scheduled by airlines caused by the pandemic has begun to recover, but order demand from airlines for new deliveries of most aircraft models remains far below

pre-pandemic

levels. The course and timing of the recovery from the

COVID-19

pandemic and its impact on the air travel industry remains unclear as virulent strains of the virus have emerged. The financial health of the airlines and airframe manufacturers is likely to remain stressed for some time, and the ultimate impact on the structure of the industry and the individual companies that comprise it is unknown. Because we are the primary source for aircraft cabin printers to the airframe manufacturers for a majority of aircraft models produced in the world, the longer-term demand for our products is defined less by the impact of

COVID-19

on particular airlines within the industry and more by the health of the industry as a whole. Although we do not know what the timing and rate of recovery will be, we do expect that the industry, and the demand for our products, will continue to recover slowly as effective vaccines become both widely available and accepted globally, and demand for air travel increases.

Demand for aerospace spare products, paper, parts and repairs has also been significantly impacted by the decline in air travel, as requirements for these products and services are based primarily upon aircraft usage. Although we have experienced minor increases in demand for spare products, paper, parts and repairs as flight hours have increased modestly since the middle of fiscal 2021, we do not know the degree to which this will continue or increase, or at what pace.

While we have reduced our costs as much as we are prudently able to, our strategy and operational plans are to maintain sufficient capabilities and staffing to fully support our customers, meet the stringent market quality requirements, and to be able to rapidly increase production as demand returns, the decline in revenue has adversely impacted our profitability.

2327

PPP Loan Forgiveness

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”) which was enacted on June 5, 2020.

On June 15, 2021, the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on extinguishment of debt, which is included in the accompanying condensed consolidated income statement for the ~~three and six months~~nine-months ended ~~July 31,2021.~~October 30, 2021.

Employee Retention Credits

The CARES Act provides an employee retention credit (“ERC”) that is a refundable tax credit against certain employer taxes. On December 27, 2020, Congress enacted the Taxpayer Certainty and Disaster Tax Relief Act of 2020, which amended and extended ERC availability under Section 2301 of the CARES Act. Before the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we were ineligible for the ERC because we received the PPP Loan. Following enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we and other businesses that received loans under that program became retroactively eligible for the ERC.

In the second quarter of the current year, we determined that we qualified for the employee retention credit of $3.1 million for wages paid in calendar year 2020 and the first calendar quarter of 2021. We ~~have~~ recorded ~~this amount as~~ a receivable in the second quarter of the current year within ~~the~~ prepaid expenses and other current assets in the condensed consolidated balance ~~sheet~~sheet. Such amount remains outstanding as of ~~July 31,~~October 30, 2021.

The $3.1 million of ERCs was recognized as a reduction in employer payroll taxes and allocated to the financial statement captions from which the ~~employee’s~~employer’s payroll taxes were originally incurred. As a result, we recorded a reduction in expenses of $1.7 million in cost of revenue, $0.8 million in selling and marketing, $0.3 million in research and development and $0.3 million in general and administrative which is included in the accompanying condensed consolidated income statement for the ~~three and six month periods~~nine months ended ~~July 31,~~October 30, 2021.

Results of Operations

Three Months Ended ~~July 31,~~October 30, 2021 vs. ~~August 1,~~October 31, 2020

Revenue by segment and current quarter percentage change over the prior year for the three months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020 were:


(Dollars in thousands)	July 31, 2021		As a % of Revenue			August 1, 2020		As a % of Revenue			% Change Compared to Prior Year			October 30, 2021		As a % of Revenue			October 31, 2020		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	23,492		78.7	%	$	21,629		78.2	%		8.6	%	$	21,928		76.0	%	$	22,898		81.7	%		(4.2	)%
T&M		6,353		21.3	%		6,029		21.8	%		5.4	%		6,929		24.0	%		5,119		18.3	%		35.4	%

Total	$	29,845		100.0	%	$	27,658		100.0	%		7.9	%	$	28,857		100.0	%	$	28,017		100.0	%		3.0	%

Revenue for the current quarter was ~~$29.8~~$28.9 million, representing an ~~8.6%~~3.0% increase compared to the prior year ~~second~~third quarter revenue of ~~$27.7~~$28.0 million. Revenue through domestic channels for the ~~second~~third quarter of the current year was ~~$17.2~~$17.3 million, ~~a decrease~~an increase of ~~3.8%~~2.9% from the prior year’s ~~second~~third quarter. International revenue for the ~~second~~third quarter of the current year was ~~$12.7~~$11.6 million, representing ~~42.4%~~40.1% of our ~~second~~third quarter revenue and reflects a ~~29.3%~~3.1% increase from the previous year ~~second~~third quarter. Current year ~~second~~third quarter international revenue includes a favorable foreign exchange rate impact of ~~$0.7~~$0.1 million.

Hardware revenue in the current quarter was ~~$7.9~~$7.6 million, a ~~6.6%~~0.6% decrease compared to the prior year’s ~~second~~third quarter ~~revenue of $8.4 million.~~revenue. The decrease is primarily attributable to the ~~T&M~~PI segment, as hardware revenue for that segment decreased ~~18.6%~~16.5% compared to the ~~second~~third quarter of the prior year. The decrease in ~~T&M~~PI segment hardware sales primarily resulted from overall decreased ~~aerospace~~sales of both the Trojan Label and QuickLabel printer product ~~line sales.~~lines, slightly offset by an increase in sales of our new Trojan Label products serving direct to package printing applications. The decline in current quarter hardware sales was also partially offset by an overall ~~9.7%~~17.0% increase in hardware sales in the PIT&M segment, as ~~well as an increase in~~a result of increased sales ~~of certain data recorders~~ in the ~~T&M~~aerospace printer product ~~group.~~line.

2428

Supplies revenue in the current quarter was ~~$18.6~~$18.1 million, a ~~9.0%~~0.3% increase compared to the prior year’s ~~second~~third quarter supplies ~~revenue of $17.0 million.~~revenue. The increase is primarily attributable to ~~the~~ higher ~~PI segment supply sales, as well as increases in revenue from~~ paper supplies sales infrom the aerospace product group in the T&M segment. This increase was partially offset by overall lower supply sales in the PI segment for the current quarter as compared to the same period in the prior year.

Service and other revenues of ~~$3.3~~$3.2 million in the current quarter increased ~~58.2%~~35.1% compared to ~~second~~third quarter revenue of ~~$2.1~~$2.4 million in the prior year. The increase is due primarily to increased repair and parts revenue related to the aerospace printer ~~and data recorder~~ product lines in the T&M segment, as well as increases in parts revenue in the Product Identification segment. The current quarter increase in service and other revenue was partially offset by lower repair and parts revenue for the data recorder product line in the T&M segment.

Current year ~~second~~third quarter gross profit was ~~$12.7~~$10.4 million, a ~~29.9%~~6.7% increase compared to prior year ~~second~~third quarter gross profit of ~~$9.8~~$9.7 million. Our current quarter gross profit margin of ~~42.6%~~36.0% reflects a ~~7.2~~1.3 percentage point increase from the prior year’s ~~second~~third quarter gross profit margin of ~~35.4%~~34.7%. The higher gross profit and related profit margin for the current quarter compared to the prior year’s ~~second~~third quarter is primarily attributable to increased revenue and the impact of the employee retention credit (“ERC”), a refundable tax credit against certain employer taxes as provided under the CARES Act, which reduced manufacturing payroll taxes, a component of cost of revenue, by $1.7 million in the second quarter of the current year.favorable product mix.

Operating expenses for the current quarter were ~~$9.3~~$10.1 million, ~~a 3.3% decrease~~an 8.3% increase compared to the prior year ~~second~~third quarter operating expenses of ~~$9.6~~$9.3 million. Specifically, current quarter selling and marketing expenses were ~~$5.1~~$5.8 million, ~~an 8.9% decrease~~a 4.0% increase compared to the ~~second~~third quarter of the prior year. The ~~decline~~increase for the current quarter in selling and marketing expenses was primarily due to ~~a decrease~~an increase in ~~payroll taxes in the second quarter of the current year related to the ERC,~~employee wage and benefits expenses, as well as an increase in advertising, trade shows and travel and entertainment expenses. The current quarter increase in selling and marketing expenses was partially offset by a decrease in amortization expense asrelated to a ~~result of changes~~change in the remaining useful lives and amortization methods for certain of our customer relationship intangibles. ~~The current quarter decline in selling and marketing expenses was partially offset by an increase in employee wages and bonuses.~~ Current quarter general and administrative expenses were ~~$2.7~~$2.4 million, a ~~5.1%~~0.5% increase compared to the ~~second~~third quarter of the prior year. ~~The~~This small increase in general and administrative expenses for the current quarter was primarily due to an increase in employee wages and ~~employee bonuses.~~benefits. This increase was partially offset by ~~a decrease in payroll taxes in the second quarter of the current year related to the ERC, as well as~~ a decrease in legal and professional fees. Research and development (“R&D”) expenses were ~~$1.5~~$1.9 million in the current quarter, a ~~5.1%~~38.0% increase compared to the ~~second~~third quarter of the prior year primarily due to increases in prototype expenses and outside service expense, as well as increased employee wages and employee ~~bonuses, partially offset by a decrease in payroll taxes related to the ERC.~~benefits The R&D spending as a percentage of revenue for the current quarter is ~~5.2%~~6.8% compared to ~~5.4%~~5.0% for the same period of the prior year.

Other ~~income~~expense in the ~~second~~third quarter of the current year was ~~$4.3~~$0.9 million compared to ~~$0.3~~other expense of $0.4 million in the ~~second~~third quarter of the prior year. Current quarter other ~~income~~expense includes ~~$4.5~~$0.7 million related to ~~forgiveness~~ the

write-off

of our ~~PPP Loan~~Oracle EnterpriseOne enterprise resource planning (“ERP”) system and related prepaid service and maintenance contracts as a result of the full implementation of our new global ERP system, interest expense on debt of $0.1 million, and a net foreign exchange ~~gain~~loss of $0.1 million. Other ~~income in the current quarter is partially offset by interest~~ expense ~~on debt of $0.2 million and other expense of $0.1 million. Other income~~ for the ~~second~~third quarter of the prior year included $0.6 million of gain on the translation of Eurodollar and Danish Kroner receivable balances at significantly higher exchange rates for those currencies as compared to the US Dollar, which were partially offset by interest expense on debt, the PPP Loan and the revolving line of credit of ~~$0.2~~$0.3 million and $0.1 million ~~related to the termination~~ of ~~the cross-currency interest rate swap.~~

net foreign exchange loss.

~~The provision for~~We recognized a federal, state and foreign income ~~taxes~~tax benefit for the ~~second~~third quarter of the current year ~~is $0.7 million,~~of $174,000, resulting in an effective tax rate of ~~9.1%~~29.0%. This rate was directly impacted by a ~~$1.1 million tax benefit from~~significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the ~~forgiveness~~end of ~~the PPP loan, a $0.1 million tax benefit arising from a windfall related to~~ our stock and a $32,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the quarter. The PPP Loan forgiveness recognized during the three months ended July 31, 2021 is excluded from taxable income under Section 1106(i)second quarter of ~~the CARES Act.~~fiscal 2022. This compares to the prior year’s ~~second~~third quarter tax ~~provision~~benefit of ~~$0.5 million,~~$32,000, resulting in an effective tax rate of ~~99.4%~~160.0%. This rate was impacted by a significant increase in forecasted operating results for our fiscal 2021 as compared to operating results forecasted at the end of our ~~first~~second quarter of fiscal year 2021, a $122,000 expense arising from a windfall shortfall tax expense related to the vesting of stock grants to directors and officers and a $79,000 expense related to return to provision adjustments from foreign tax returns filed in the quarter.2021.

We reported a net ~~income~~loss of ~~$7.0~~$0.4 million or ~~$0.96~~$0.06 per ~~diluted~~basic share for the ~~second~~third quarter of the current year. The results for the current quarter were impacted by ~~income~~expense of ~~$4.5~~$0.7 million ($~~4.4~~0.5 million net of tax or ~~$0.60~~$0.07 per diluted share) related to the ~~gain on extinguishment~~

write-off

of ~~debt for~~ the ~~PPP Loan forgiveness~~Oracle EnterpriseOne ERP system and ~~income of $3.1 million ($2.4 million net of tax or $0.32 per diluted share)~~ related ~~to the ERC.~~prepaid service and maintenance contracts. Net income for the prior year’s ~~second~~third quarter was ~~$3,000~~$12,000 or $0.00 per diluted share. Return on revenue was ~~23.5%~~negative 1.5% for the current quarter of fiscal 2022 compared to 0.0% for the prior year ~~second~~third quarter of fiscal 2021.

2529

~~Six~~Nine Months Ended ~~July 31,~~October 30, 2021 vs. ~~Six~~Nine Months Ended ~~August 1,~~October 31, 2020

Revenue by segment and current period percentage change over the prior year for the ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020 were:


(Dollars in thousands)	July 31, 2021		As a % of Revenue			August 1, 2020		As a % of Revenue			% Change Compared to Prior Year			October 30, 2021		As a % of Revenue			October 31, 2020		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	46,590		79.1	%	$	44,009		75.1	%		5.9	%	$	68,519		78.1	%	$	66,907		77.3	%		2.4	%
T&M		12,333		20.9	%		14,569		24.9	%		(15.3	)%		19,261		21.9	%		19,688		22.7	%		(2.2	)%

Total	$	58,923		100.0	%	$	58,578		100.0	%		0.6	%	$	87,780		100.0	%	$	86,595		100.0	%		1.4	%

Revenue for the first ~~six~~nine months of the current year was ~~$58.9~~$87.8 million, representing a ~~slight~~1.4% increase compared to the previous year’s first ~~six~~nine months revenue. Revenue through domestic channels for the first ~~half~~nine months of the current year was ~~$33.9~~$51.2 million, a decrease of ~~10.0%~~6.0% from prior year domestic revenue of ~~$37.7~~$54.4 million. International revenue for the first ~~six~~nine months of the current year was ~~$25.0~~$36.6 million, a ~~19.7%~~13.9% increase from the previous year international revenue of ~~$20.9~~$32.2 million. The current year’s first ~~six~~nine months international revenue reflected a favorable foreign exchange rate impact of ~~$1.5~~$1.6 million.

Hardware revenue in the first ~~six~~nine months of the current year was ~~$15.5~~$23.2 million, a ~~10.5%~~7.5% decrease compared to the prior year’s first ~~six~~nine months hardware revenue of ~~$17.4~~$25.0 million. The decrease in hardware revenue is primarily due to ~~a 30.1%~~an 18.4% decline in hardware sales in the T&M segment resulting from overall lower aerospace printer product line and data recorder sales. The decline in the first ~~six~~nine months revenue was partially offset by ~~increased~~an 8.1% increase in hardware sales for the first ~~six~~nine months of the current year in the PI ~~segment.~~segment primarily related to increased sales of the Trojan Label -products serving direct to package printing applications.

Supplies revenue in the first half of the current year was ~~$36.9~~$54.9 million, representing a ~~1.7%~~1.3% increase over prior year’s first ~~six~~nine months supplies revenue of ~~$36.3~~$54.3 million. The increase in the current year supplies revenue is primarily attributable to the increase in sales of supplies in the T&M segment as well as an increase in sales of ink ~~and media~~jet supplies in the PI ~~segment as well as paper supplies in the aerospace product group in the T&M~~ segment. .

Service and other revenues were ~~$6.5~~$9.7 million in the first ~~six~~nine months of the current year, a ~~31.1%~~32.4% increase compared to the prior year’s first ~~six~~nine months service and other revenues of ~~$4.9~~$7.3 million. The increase is due primarily to overall increased repair and parts revenue in both the T&M and PI segments.

Current year first ~~six~~nine months gross profit was ~~$23.6~~$34.0 million, ~~a 14.3%~~an 11.9% increase from prior year’s first ~~six~~nine months gross profit of ~~$20.6~~$30.4 million. Our gross profit margin of ~~40.1%~~38.7% in the current year reflects ana 3.6 percentage point increase from the prior year’s first ~~six~~nine months gross profit margin of ~~35.2%~~35.1%. The higher gross profit and related profit margin for the current year compared to the prior year is primarily attributable to increased revenue, lower manufacturing period costs and the impact of the ERC, which reduced manufacturing payroll taxes in the amount of $1.7 million in the second quarter of the current year.

Operating expenses for the first ~~six~~nine months of the current fiscal year were ~~$19.4~~$29.5 million, a ~~1.8% decrease~~1.4% increase compared to the prior year’s first ~~six~~nine months operating expenses of ~~$19.8~~$29.1 million. Selling and marketing expenses for the current year of ~~$11.2~~$16.9 million decreased by ~~2.8%~~0.6% compared to the previous year’s first ~~six~~nine months primarily due to a decrease in payroll taxes in the second quarter of the current year related to the ERC, as well as a decrease in amortization expense related to athe second quarter’s change in the remaining useful lives and amortization methods for certain of our customer relationship intangibles. The current year decline in selling and marketing expenses was partially offset by an increase in employee wages and bonuses as well as increased travel and entertainment ~~expenses.~~expenses and commissions. General and administrative expenses increased ~~3.0%~~2.2% to ~~$5.0~~$7.4 million in the first ~~six~~nine months of the current year compared to ~~$4.9~~$7.2 million in the first ~~six~~nine months of the prior year, primarily due to an increase in employee wages, bonuses and fees, partially offset by a decrease in payroll taxes related to the ERC, as well as a decrease in outside service ~~expenses.~~expenses and professional fees. R&D spending in the first ~~six~~nine months of the current year was ~~$3.3~~$5.2 million, a ~~5.2% decrease~~7.4% increase compared to the prior year’s first ~~six~~nine months spending of ~~$3.4~~$4.8 million primarily due to an increase in employee benefits and prototype expenses. The current year increase in R&D was partially offset due to a ~~decrease~~decline in payroll taxes related to the ~~ERC, partially offset by increases in employee wages and bonuses .~~ERC. Current year spending on R&D represents ~~5.5%~~5.9% of revenue compared to the prior year’s first ~~six~~nine months level of ~~5.9%~~5.6%.

Other income during the first ~~six~~nine months of the current year was ~~$3.9~~$3.0 million compared to ~~$23,000~~other expense of ~~other expense~~$0.5 million in the first ~~six~~nine months of the previous year. Current year other income includes $4.5 million related to the forgiveness of our PPP Loan, partially offset by $0.7 million related to the

write-off

of our Oracle EnterpriseOne ERP system and related prepaid service and maintenance contracts in anticipation of the full implementation of our new global ERP system, interest expense on debt of ~~$0.4~~$0.5 million, ~~and~~ net foreign exchange loss of $0.2 million and other expense of $0.1 million. Other expense during the first ~~six~~nine months of the prior year ~~of $23,000~~ primarily included $0.8 million of interest expense ~~of $0.5 million~~ on our debt, PPP Loan and revolving credit line, ~~and~~ $0.1 million of loss related to the termination of the cross-currency interest rate swap and other expense of $0.1, offset by a ~~$0.5~~$0.4 million gain on the translation of Eurodollar and Danish Kroner receivable balances at significantly higher exchange rates for those currencies as compared to the US Dollar and investment income of $0.1 million.

2630

We recognized ~~$0.5~~$0.3 million of income tax expense for the first ~~six~~nine months of the current fiscal year, ~~which reflects~~resulting in an effective tax rate of 4.0%. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our second quarter of fiscal 2022, a $1.1 million tax benefit from the forgiveness of ~~our~~the PPP Loan, a $0.1 million tax benefit arising from windfall tax expense related to our stock, a ~~$32,000~~$30,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the year, and a $0.3 million tax benefit related to the expiration of the statute of limitations on previously uncertain tax ~~positions and results in a 5.8% effective tax rate.~~positions. The PPP ~~loan~~Loan forgiveness recognized ~~during the six months ended July 31, 2021~~ is excluded from taxable income under Section 1106(i) of the CARES Act. We recognized $0.4 million of income tax expense for the first ~~six~~nine months of the prior fiscal year, which reflected a significant increase in forecasted operating results for our fiscal 2021 as compared to operating results forecasted at the end of our ~~first~~second quarter of fiscal 2021, a $118,000 expense arising from a shortfall tax expense related to our stock, a $79,000 expense related to return to provision adjustments from several foreign tax returns filed in the current year and a $78,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions resulting in a ~~48.6%~~45.9% effective tax rate.

We reported net income of ~~$7.6~~$7.2 million, or ~~$1.04~~$1.00 per diluted share, for the first ~~six~~nine months of the current year. The results for the current period were impacted by income of $4.5 million ($4.4 million net of tax or ~~$0.61 per diluted share) related forgiveness of our PPP Loan and income of $3.1 million ($2.4 million net of tax or $0.33~~$0.60 per diluted share) related to the ~~ERC.~~forgiveness of our PPP Loan, income of $2.1 million ($1.6 million net of tax or $0.22 per diluted share) related to the net ERC and expense of $0.7 million ($0.5 million net of tax or $0.07 per diluted share) related to the

write-off

of the Oracle EnterpriseOne ERP system and related prepaid service and maintenance contracts. On a comparable basis, net income for the prior year’s first ~~six~~nine months was $0.4 million or $0.06 per diluted share. Return on revenue was ~~12.9%~~8.2% for the first ~~six~~nine months of fiscal 2022 compared to ~~0.7%~~0.5% for the first ~~six~~nine months of fiscal 2021.

Segment Analysis

We report two segments: Product Identification and Test & Measurement and evaluate segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit (Loss) for each reporting segment:


	Three Months Ended									Six Months Ended									Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)					Revenue				Segment Operating Profit (Loss)					Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	July 31, 2021		August 1, 2020		July 31, 2021		August 1, 2020			July 31, 2021		August 1, 2020		July 31, 2021		August 1, 2020			October 30, 2021		October 31, 2020		October 30, 2021			October 31, 2020			October 30, 2021		October 31, 2020		October 30, 2021		October 31, 2020
Product Identification	$	23,492	$	21,629	$	4,406	$	3,146		$	46,590	$	44,009	$	7,134	$	6,292		$	21,928	$	22,898	$	1,818		$	3,521		$	68,519	$	66,907	$	8,952	$	9,813
T&M		6,353		6,029		1,710		(407	)		12,333		14,569		2,060		(563	)		6,929		5,119		842			(751	)		19,261		19,688		2,902		(1,314	)

Total	$	29,845	$	27,658		6,116		2,739		$	58,923	$	58,578		9,194		5,729		$	28,857	$	28,017		2,660			2,770		$	87,780	$	86,595		11,854		8,499

Corporate Expenses						2,664		2,535							5,008		4,861							2,364			2,353							7,372		7,214

Operating Income						3,452		204							4,186		868							296			417							4,482		1,285
Other Income (Expense), Net						4,266		328							3,897		(23	)						(895	)		(437	)						3,002		(459	)

Income Before Income Taxes						7,718		532							8,083		845
Income Tax Provision						699		529							471		411
Income (Loss) Before Income Taxes																								(599	)		(20	)						7,484		826
Income Tax Provision (Benefit)																								(174	)		(32	)						297		379

Net Income					$	7,019	$	3						$	7,612	$	434
Net Income (Loss)																							$	(425	)	$	12						$	7,187	$	447

Product Identification

Revenue from the Product Identification segment ~~increased 8.6%~~decreased 4.2% in the ~~second~~third quarter of the current year, with revenue of ~~$23.5~~$21.9 million compared to ~~$21.6~~$22.9 million in the same period of the prior year. The current quarter ~~increase~~decrease is primarily due to a net overall ~~increased~~decrease in hardware revenue, as well as an overall decrease in supplies sales infor both the QuickLabel and Trojan Label product lines. ~~Also contributing to the increase is a net overall increase~~The current quarter decline in ~~hardware~~ revenue ~~aided~~was partially offset by ~~strong~~increased sales of the new TrojanLabel

~~T3-OPX~~

printer products, as well as increased current quarter revenue from parts sales. Product Identification’s current quarter segment operating profit was ~~$4.4~~$1.8 million, reflecting a profit margin of ~~18.8%~~8.3% and compares to the prior year’s ~~second~~third quarter segment profit of ~~$3.1~~$3.5 million and related profit margin of ~~14.5%~~15.4%. The ~~increase~~decrease in Product Identification current year ~~second~~third quarter segment operating profit and margin is primarily due ~~to increased~~the decline in revenue and ~~the impact of the ERC which reduced~~increased manufacturing, period costs and operating ~~payroll taxes attributable to the PI segment by $1.9 million in the second quarter of the current year.~~expenses.

2732

Revenue from the Product Identification segment increased ~~5.9%~~2.4% to ~~$46.6~~$68.5 million in the first ~~six~~nine months of the current year from ~~$44.0~~$66.9 million in the same period of the prior year. The current year increase is primarily due to ~~increased supplies. Also contributing to the increase is~~ a net increase in overall hardware revenue, aided by strong sales of ~~the~~ new TrojanLabel

~~T3-OPX~~

printer products, as well as increased current year revenue for ink jet supplies and parts and repairs ~~in both the QuickLabel and Trojan Label product lines.~~revenue. Product Identification current year segment operating profit was ~~$7.1~~$9.0 million with a profit margin of ~~15.3%~~13.1%, compared to the prior year segment operating profit of ~~$6.3~~$9.8 million and related profit margin of ~~14.3 %.~~14.7%. The ~~increase~~decrease in current year segment operating profit and margin is primarily due to increased ~~revenue and the impact of the ERC which reduced manufacturing and~~ operating ~~payroll taxes attributable to the PI segment by $1.9 million in the second quarter of the current year.~~expenses.

Test & Measurement—T&M

Revenue from the T&M segment was ~~$6.4~~$6.9 million for the ~~second~~third quarter of the current fiscal year, representing a ~~5.4%~~35.4% increase compared to revenue of ~~$6.0~~$5.1 million for the same period in the prior year. The increase in revenue for the current quarter is primarily attributable to the increase in hardware, supplies and repairs and parts revenue in our aerospace product ~~group, as well as increased supplies sales in the aerospace product group. Also contributing to the second quarter growth was the increase in sales of TMX hardware sales in the T&M product~~ group. The increase for the ~~second~~third quarter is partially offset by the decline in current quarter data recorder hardware sales ~~as a result of~~in the ~~Boeing 737 MAX aircraft grounding and the dramatic drop in air travel due to the impact of~~

~~COVID-19.~~

T&M product group. T&M’s ~~second~~third quarter segment operating profit was ~~$1.7~~$0.8 million, reflecting a profit margin of ~~26.9%~~12.2%, an increase compared to the prior year segment operating loss of ~~$0.4~~$0.8 million and related negative operating margin of ~~6.8%~~14.7%. The increase in segment operating profit and related margin were due to increased revenue and ~~the impact of the ERC which reduced manufacturing and~~lower operating ~~payroll taxes attributable to the T&M segment by $1.1 million in the second quarter of the current year.~~expenses.

Revenue from the T&M segment was ~~$12.3~~$19.3 million for the first ~~six~~nine months of the current fiscal year, a ~~15.3%~~2.2% decrease compared to sales of ~~$14.6~~$19.7 million for the same period in the prior year. The decrease in revenue for the current year is primarily attributable to the overall decline in hardware sales of ~~our~~both the aerospace ~~product group as a result of the Boeing 737 MAX grounding~~printer and ~~the dramatic drop in air travel due to the impact of the~~

~~COVID-19~~

~~pandemic. The decrease in current period revenue was also driven to a lesser degree by a decline in~~ data recorder ~~hardware sales in the T&M~~ product ~~group.~~lines. The decline in revenue was partially offset by increased supplies and parts and repairs revenue in the aerospace product group, as well as increased sales of TMX hardware sales in the T&M product group. The segment’s first ~~six~~nine months operating profit of ~~$2.1~~$2.9 million resulted in a ~~16.7%~~15.1% profit margin compared to the prior year segment operating loss of ~~$0.6~~$1.3 million and related negative operating margin of ~~3.9%~~6.7%. The increase in segment operating profit and related margin for the current year is primarily due ~~the impact of the employee retention credit which reduced~~to lower manufacturing and operating ~~payroll taxes attributable to the T&M segment by $1.1 million in the second quarter of the current year.~~expenses.

Financial Condition and Liquidity

Overview

Historically, our primary sources of short-term liquidity have been cash generated from operating activities and borrowings under our revolving credit facility. These sources have also usually funded the majority of our capital expenditures and contractual contingent consideration obligations. We have funded acquisitions by borrowing under bank term loan facilities.

On July 30, 2020, we entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with ~~the~~ Bank of America, N.A. (the “Lender”), our wholly owned subsidiary ANI ApS, a Danish private limited liability company and ANI ApS’s wholly-owned subsidiary TrojanLabel ApS, a Danish private limited liability company (“TrojanLabel”). The A&R Credit Agreement amended and restated the Credit Agreement dated as of February 28, 2017 by and among us, ANI ApS, TrojanLabel and the Lender. In connection with our entry into the A&R Credit Agreement, we entered into an Amended and Restated Security and Pledge Agreement and a mortgage in favor of the Lender with respect to our owned real property in West Warwick, Rhode Island. Under the A&R Credit Agreement, AstroNova, Inc. is the sole borrower, and its obligations are guaranteed by ANI ApS and TrojanLabel.

On March 24, 2021, we entered into a First Amendment to Credit Agreement (the “Amendment”) to our A&R Credit Agreement (the “A&R Credit Agreement amended by the Amendment, the “Amended Credit Agreement”) with the Lender, ANI ApS and TrojanLabel. Immediately prior to the closing of the Amendment, we repaid $ 2.6 million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $10.0 million and no amount drawn and outstanding under the revolving credit facility under the Amended Credit Agreement.

The Amended Credit Agreement expires on September 30, 2025, a significant extension of tenor. It also eliminated a minimum adjusted EBITDA covenant, an asset coverage covenant and a minimum liquidity covenant, and, subject to ongoing covenant compliance, significantly reduced limitations on restricted payments such as dividends, eliminated restrictions on capital expenditures and increased operating flexibility with respect to funding our global operations.

2833

The Amended Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million, and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amended Credit Agreement, we borrowed the entire $10.0 million term loan which was used to refinance in full the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

While we have expected that as a result of the impact of the

COVID-19

pandemic, some of our customers would experience liquidity pressure and be unable to pay us for products on a timely basis, in general our recent receivables collection experience has been consistent with our historical experience and a significant deterioration in receivables collection has not occurred.

In response to the

COVID-19

pandemic and related economic dislocation, we have implemented and will continue to implement a variety of expense reduction and cash preservation initiatives. On April 27, 2020, our board of directors suspended our quarterly cash dividend beginning with the second quarter of our fiscal year 2021.

At ~~July 31,~~October 30, 2021, our cash and cash equivalents were ~~$11.4~~$8.7 million. There was no outstanding balance on our revolving line of credit at ~~July 31,~~October 30, 2021 and we have $22.5 million available for borrowing under that facility. We believe that our available cash and credit facilities combined with our cash generated from operations will be sufficient to support our operating requirements, so long as the impact of

COVID-19

does not worsen.

Indebtedness

Term Loan

The Amended Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10,000,000, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

The interest rates under the A&R Credit Agreement were modified in the Amended Credit Agreement as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the LIBOR Rate as defined in the A&R Credit Agreement (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the LIBOR Rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30% based on our consolidated leverage ratio.

2934

We must comply with various customary financial and

non-financial

covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The minimum EBITDA, minimum consolidated asset coverage ratio, minimum liquidity and maximum capital expenditures covenants with which we were required to comply under the A&R Credit Agreement were eliminated by the Amendment. The primary

non-financial

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held by us in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island. Pursuant to the Amendment, the guarantees of our obligations under the A&R Credit Agreement that were previously provided by ANI ApS and TrojanLabel were released.

PPP Loan

On May 6, 2020, we entered into a Loan Agreement with and executed a promissory note in favor of Greenwood Credit Union ~~(“Greenwood”)~~ pursuant to which we borrowed $4.4 million ~~(the “PPP Loan”)~~ from Greenwood pursuant to the Paycheck Protection Program ~~(the “PPP”)~~ administered by the United States Small Business Administration (the “SBA”) and authorized by the ~~Coronavirus Aid, Relief, and Economic Security~~CARES Act ~~(the “CARES Act”),~~ enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020, ~~(the “PPP Flexibility Act”),~~ which was enacted on June 5, 2020. We believe that our obtaining the PPP Loan and suspending the payment of dividends on our common stock were instrumental in our ability to successfully negotiate the A&R Credit Agreement.

The PPP Loan, which would have matured on May 6, 2022, iswas unsecured and bore interest at a rate of 1.0% per annum, accruing from the loan date. No payments ~~were~~would have been due on the PPP Loan until the date on which the lender ~~determines~~determined the amount of the PPP Loan that iswas eligible for forgiveness.

Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act, and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan may be forgiven in an amount up to the amount of the PPP Loan proceeds that we spent on payroll, rent, utilities and interest on certain debt during the twenty-four-week period following incurrence of the PPP Loan. Interest accrued on the forgiven portion of the principal amount of the PPP Loan is also forgiven. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40% of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. We have fully utilized the PPP Loan proceeds for qualifying expenses during fiscal year 2021. The PPP Loan was classified as long-term debt in the condensed consolidated balance sheet until the forgiveness determination was made by the SBA.

On June 15, 2021, Greenwood notified us that the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on extinguishment of debt in ~~Other Income (Expense)~~other income (expense) which is included in our condensed consolidated income statement for the ~~three and six~~nine months ended ~~July 31,2021.~~October 30, 2021.

Cash Flow

Our statements of cash flows for the ~~six~~nine months ended ~~July 31,~~October 30, 2021 and ~~August 1,~~October 31, 2020 are included on page 78 of this report. Net cash provided by operating activities was ~~$5.5~~$3.8 million for the first ~~six~~nine months of fiscal 2022 compared to ~~$9.2~~$11.7 million for the same period of the previous year. The decrease in net cash provided by operations for the first ~~six~~nine months of the current year is primarily due to the decrease in cash provided by working capital. The combination of changes in accounts receivable, inventory, income taxes payable, accounts payable and accrued expenses increased cash by ~~$2.7~~$0.1 million for the first ~~six~~nine months of fiscal 2022, compared to an increase of ~~$5.7~~$6.1 million for the same period in fiscal 2021. The decrease in cash from operations for the first ~~six~~nine months of fiscal 2022 was also impacted by the $3.1 million ERC receivable due at ~~July 31, 2021.~~October 30, 2021 and the $4.5 million gain on the forgiveness of the PPP Loan.

Our accounts receivable balance decreased to ~~$15.6~~$16.4 million at the end of the ~~second~~third quarter compared to $17.4 million at year end. The ~~$1.8~~$1.0 million decrease in the accounts receivable balance from year end is related to the sales product mix for the ~~second~~third quarter of the current year as compared to fourth quarter sales in fiscal 2021. Days sales outstanding for the ~~six~~nine months of fiscal 2022 is 4547 compared to 51 days at prior year end.

3035

The inventory balance was ~~$29.1~~$31.7 million at the end of the ~~second~~third quarter of fiscal 2022, a ~~small decline~~slight increase compared to $30.1 million at year end. Inventory days on hand increased to ~~153~~154 days at the end of the current quarter from 147 days at the prior year end.

The net cash position at ~~July 31,~~October 30, 2021 ~~remained consistent~~decreased to $8.7 million compared with the year end balance atof $11.4 million. ~~Cash was primarily provided from the working capital accounts, as discussed above.~~ Cash outflows during the first ~~six~~nine months of fiscal 2022 included the refinancing of debt, which resulted in a net outflow of cash of $2.6 million, cash used to acquire property, plant and equipment of ~~$1.2~~$1.5 million and principal payments on the new long-term debt and the guaranteed royalty obligation of ~~$0.4~~$0.6 million and ~~$1.0~~$1.5 million, respectively.

Contractual Obligations, Commitments and Contingencies

There have been no material changes to our contractual obligations as disclosed in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021 other than those occurring in the ordinary course of business.

Critical Accounting Policies, Commitments and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly

re-evaluate

these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. There have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021.

Forward-Looking Statements

This Quarterly Report on Form

10-Q

may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) the impact of the ongoing

COVID-19

pandemic on us, our customers, our suppliers and the global economy; (c) declining demand in the test and measurement markets, especially defense and aerospace; (d) our ability to develop and introduce new products and achieve market acceptance of these products; (e) difficulties encountered in connection with the certification of the 737 MAX for return to service; (f) our dependance on contract manufactures and/or single or limited source suppliers; (g) competition in the specialty printer or data acquisition industries; (h) our ability to obtain adequate pricing for our products and control our cost structure; (i) our ability to adequately enforce and protect our intellectual property, defend against assertions of infringement or loss of certain licenses; (j) the risk of a material security breach of our information technology system or cybersecurity attack impacting our business and our relationship with customers; (k) any technology disruption or delay in implementing new technology or our new global ERP system; (l) our ability to attract, develop and retain key employees; (m) economic, political and other risks associated with international sales and operations and the impact of changes in

3136

foreign currency exchange rates on the results of operations; (n) changes in tax rates or exposure to additional income tax liabilities; (o) our ability to comply with our current credit agreement or secure alternative financing and to otherwise manage our indebtedness; (p) our ability to successfully integrate acquisitions and realize benefits from divestitures; (q) our ability to maintain adequate self-insurance accruals or insurance coverage for employee health care benefits; (r) our compliance with customer or regulators certifications and our compliance with certain governmental laws and regulations; and (s) other risks included under

“Item 1A-Risk

Factors” in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2021. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

During the ~~six~~nine months ended ~~July 31,~~October 30, 2021, there were no material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form

10-K

for the year ended January 31, 2021.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to

Rule 13a-15(b)

under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

There are no pending or threatened legal proceedings against us that we believe to be material to our financial position or results of operations.

Item 1A.

Risk Factors

This section augments and updates certain risk factors disclosed in Item 1A of Part I of our Annual Report on Form

10-K

for the year ended January 31, 2021 (the “Annual Report”). We are providing the following information regarding changes that have occurred to the previously disclosed risk factors in our Annual Report on

Form 10-K.

In addition to the other information in this Quarterly Report on Form

10-Q,

all risk factors should be carefully considered in evaluating us and our common stock. Any of these risks, many of which are beyond our control, could materially and adversely affect our financial condition, results of operations or cash flows, or cause our actual results to differ materially from those projected in any forward-looking statements. We may also face other risks and uncertainties that are not presently known, are not currently believed to be material, or are not identified below because they are common to all businesses. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. For more information, see “Forward-Looking Statements” elsewhere in this Quarterly Report.

The ongoing

COVID-19

pandemic has adversely affected and will likely continue to adversely affect our revenues, results of operations and financial condition.

Our business has been and likely will continue to be materially adversely affected by the global

COVID-19

pandemic. We operate in several regions of the world, with the largest concentration of team members in North America and Europe, and a smaller presence in Asia. Since the

COVID-19

pandemic began, we have monitored government recommendations and regulations in the areas where we operate and have made good faith efforts to comply with regulations, , best practices and recommendations issued by a variety of governmental health authorities and manufacturing industry organizations to which we belong. Throughout the pandemic we, and many other businesses and organizations with which we do business directly or otherwise impact us, have taken steps to avoid or reduce infection as recommended by the public health authorities, including enabling teammates to work remotely from home and by limiting business travel and gatherings of people.

3237

by limiting business travel and gatherings of people. Although vaccine availability has expanded dramatically in the market economies where the majority of our revenues are derived this has not been true throughout the world, and even in our major market areas, inoculation rates have not been sufficient to prevent another surge of infections as more virulent strains of

~~COVID-19~~

have emerged. Recommendations against gatherings of people and travel restrictions between regions had loosened to varying degrees in some locations, but many have still remained in place or have been reinstated, especially in Europe. It is impossible to determine the precise impact that the future course of the pandemic will have on our business. For example, some of the health practices that were instituted at the height of the pandemic care again being recommended and in some cases imposed. At this point it is still unclear how the future course of the pandemic will evolve and how the public health authorities in the United States, Europe and Asia will respond. Accordingly, and we cannot determine exactly how our own business practices and those of with whom we do business will respond as a result.

We made significant modifications to our normal operations because of the

COVID-19

pandemic, including requiring most

non-production

related team members to work remotely, at least part-time. As athe result of declining infection rates in early 2021, and in response to guidance from local and national health authorities we relaxed some of our health-related workplace restrictions and practices. ~~We do not know when, or if, it will become practical~~However, we anticipate reverting to ~~further relax or eliminate~~more stringent workplace restrictions as the ~~remaining restrictions, altogether, or whether~~winter months near and the ~~emergence of more virulent strains of~~

~~COVID-19~~

~~will cause us to impose additional restrictions.~~omicron variant emerges. Since the start of the pandemic, we have maintained most of the manufacturing operational capacity at our facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany. In the West Warwick and Canadian operations there were periods when a number of team members were unable to maintain their work schedules due to the effects of the pandemic, which resulted in reduced production capacity, longer order fulfillment lead times, and as a result, reduced revenues. ~~While those issues~~Those direct impacts of the pandemic, to a large degree, have ~~abated to some degree, they are still impacting our operations. The extent to which the~~

~~COVID-19~~

~~variants, the continued efficacy of vaccinations and the willingness of our employees and others to become vaccinated, among others.~~abated. We expect that our operations and modalities of

on-site

and remote work will be impacted permanently, ~~and~~as will our increased safety protocols and the other adaptations undertaken during the pandemic, ~~may be instituted permanently,~~ but we our practices and plans are still developing our plans and we cannot ~~yet~~ predict the result yet.

Vaccinations against the viruses that cause the COVID have become a prevalent but not universally accepted response to mitigating infection risk. Although vaccination rates have continued to increase among our workforce and in the market economies where the majority of ~~these actions.~~our revenues are derived, infection rates continue to surge in various regions as more virulent strains of

COVID-19

have recently emerged. These case rates have led to further travel restrictions imposed by various countries, and although not directly impacting our business activities, it is uncertain at this time what further travel restrictions may be imposed. It is impossible to determine the precise impact that the future course of the pandemic will have on our business. For example, some of the health practices that were instituted at the height of the pandemic are again being recommended, and in some cases

re-imposed.

Since the

COVID-19

The aerospace industry, which we serve through our aerospace product line, has also been significantly disrupted by the

COVID-19

pandemic, both inside and outside of the United States. The decline in air travel has had and will continue to have a material adverse impact on our financial results, the ultimate scope of which we cannot estimate at this time. Should one or more of our airplane OEM manufacturing customers or a significant number of airline customers fail to continue business as a going concern, declare bankruptcy, or otherwise permanently reduce the demand for our products as a result of the impact of the

COVID-19

pandemic, it would have a material adverse impact on our business operations and financial results.

While it is not possible at this time to estimate the full scope of the impact that

COVID-19

will have on our business, customers, suppliers or other business partners, we expect that the lasting presence of

COVID-19

will continue to adversely impact our operational capacity and the efficiency of our team members and will continue to negatively affect our results of operations and financial condition for the near term.

3338

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

During the ~~second~~third quarter of fiscal 2022, we made the following repurchases of our common stock:

Total Number
of Shares
Repurchased

Average
Price paid
Per Share

Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs

Maximum Number
of Shares That
May Be Purchased
Under The Plans
or Programs

May 1—May 31
   —      $ —   —      —
June 1—June 30
   9,268 (a) $ 15.71 (a) —      —
July 1—July 31
   —   $ —   —      —


	Total Number of Shares Repurchased			Average Price paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares That May Be Purchased Under The Plans or Programs
August 1—August 31		—		$	—			—		—
September 1—September 30		160	(a)	$	16.25	(a)		—		—
October 1—October 31		—		$	—			—		—

(a)

~~Certain~~One of our ~~executives~~employees delivered ~~9,268~~160 shares of our common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a ~~weighted-average~~ market value of ~~$15.71~~$16.25 per share and are included with treasury stock in the consolidated balance sheet. ~~These transactions were~~This transaction was not part of a publicly announced purchase plan or program.

3439

Item 6.

Exhibits


3A		Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.

3B		By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form 10-K/A for the fiscal year ended January 31, 2008 (File no. 000-13200) and incorporated by reference herein.

10.1*		Form of Indemnification Agreement for directors and officers.

31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

		101.SCH Inline XBRL Taxonomy Extension Schema Document

		101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

		101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document

		101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

		101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	ASTRONOVA, INC.
	(Registrant)

Date: ~~September 14,~~December 9, 2021	By	/s/ Gregory A. Woods
		Gregory A. Woods,
		President and Chief Executive Officer
		(Principal Executive Officer)

	By	/s/ David S. Smith
		David S. Smith,
		Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

3641


	July 31, 2021			January 31, 2021
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	11,389		$	11,439
Accounts Receivable, net		15,603			17,415
Inventories, net		29,090			30,060
Prepaid Expenses and Other Current Assets		5,317			1,807

Total Current Assets		61,399			60,721
Property, Plant and Equipment, net		12,307			12,011
Intangible Assets, net		20,074			21,502
Goodwill		12,623			12,806
Deferred Tax Assets		5,942			5,941
Right of Use Assets		1,209			1,389
Other Assets		1,680			1,103

TOTAL ASSETS	$	115,234		$	115,473

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	6,131		$	5,734
Accrued Compensation		3,917			2,852
Other Liabilities and Accrued Expenses		3,666			3,939
Current Liability – Royalty Obligation		2,000			2,000
Current Portion of Long-Term Debt		875			5,326
Current Liability – Excess Royalty Payment Due		24			177
Deferred Revenue		324			285
Income Taxes Payable		—			655

Total Current Liabilities		16,937			20,968
Long-Term Debt, net of current portion		8,641			7,109
Royalty Obligation, net of current portion		5,261			6,161
Long-Term Debt – PPP Loan		—			4,422
Lease Liabilities, net of current portion		907			1,065
Other Long-Term Liabilities		557			681
Deferred Tax Liabilities		354			384

TOTAL LIABILITIES		32,657			40,790
SHAREHOLDERS’ EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,554,475 shares and 10,425,094 shares at July 31, 2021 and January 31, 2021, respectively		526			521
Additional Paid-in Capital		59,078			58,049
Retained Earnings		57,697			50,085
Treasury Stock, at Cost, 3,321,955 and 3,297,058 shares at July 31, 2021 and January 31, 2021, respectively		(33,942	)		(33,588	)
Accumulated Other Comprehensive Loss, net of tax		(782	)		(384	)

TOTAL SHAREHOLDERS’ EQUITY		82,577			74,683

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	115,234		$	115,473


	Common Stock				Additional Paid-in Capital			Retained Earnings			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
	Shares		Amount		Additional Paid-in Capital			Retained Earnings			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
Balance January 31, 2020		10,343,610	$	517	$	56,130		$	49,298		$	(33,477	)	$	(1,093	)	$	71,375
Share-Based Compensation		—		—		495			—			—			—			495
Employee Option Exercises		4,456		—		32			—			—			—			32
Restricted Stock Awards Vested, net		23,638		1		(1	)		—			(54	)		—			(54	)
Common Stock – Cash Dividend - $0.07 per share		—		—		—			(497	)		—			—			(497	)
Net Income		—		—		—			432			—			—			432
Other Comprehensive Loss		—		—		—			—			—			(221	)		(221	)

Balance May 2, 2020		10,371,704	$	518	$	56,656		$	49,233		$	(33,531	)	$	(1,314	)	$	71,562
Share-Based Compensation		—		—		601			—			—			—			601
Employee Option Exercises		4,874		—		29			—			—			—			29
Restricted Stock Awards Vested, net		35,676		2		(2	)		—			(37	)		—			(37	)
Net Income		—		—		—			3			—			—			3
Other Comprehensive Income		—		—		—			—			—			399			399

Balance August 1, 2020		10,412,254	$	520	$	57,284		$	49,236		$	(33,568	)	$	(915	)	$	72,557


	Total Number of Shares Repurchased			Average Price paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares That May Be Purchased Under The Plans or Programs
May 1—May 31		—		$	—			—		—
June 1—June 30		9,268	(a)	$	15.71	(a)		—		—
July 1—July 31		—		$	—			—		—

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company